Second line medication for Crohn's disease

RX_CROHN_2NDLINE

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Medicine purchases: ATC — L04AX\|L01BB02 1 out of 7 registries used, show all original rules.	29351
4. Check minimum number of events Min. number of events 3	29351
5. Include endpoints None	29351
6. Filter based on genotype QC (FinnGen only)	29351

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF5

NAME	RX_CROHN_2NDLINE
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC	L04AX\|L01BB02
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Second line medication for Crohn's disease based on the number of shared cases.

Similar with more cases:

Any prescribed medicine buy

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	143874	84541	58823
Only index persons	136668	80893	55775
Unadjusted period prevalence (%)
Whole population	2.10	2.42	1.64
Only index persons	2.63	2.97	2.13
Median age at first event (years)
Whole population	53.34	53.97	52.43
Only index persons	53.04	53.70	52.07

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	29351	18132	11219
Unadjusted period prevalence (%)	5.71	6.18	4.95
Median age at first event (years)	52.70	51.55	54.56

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
25585: Matched controls
255688

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

A07EA06

ATC

budesonide; oral, local oral

13.5

323.0

2823

2319

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

16.7

323.0

4515

3234

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

66.4

323.0

16105

6366

319

Kela drug reimbursment

Adalimumab, brodalumab, certolizumab pegol, etanercept, guselkumab, infliximab, ixekizumab, risankizumab, sekukinumab and ustekinumab (skin psoriasis)

45.2

323.0

515

116

A02BC02

ATC

pantoprazole; systemic

2.2

323.0

17295

123140

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

13.2

323.0

1388

1107

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

5.4

323.0

13896

45908

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

40.8

323.0

3265

914

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

11.1

323.0

867

805

K51.0

ICD-10 Finland

Ulcerative (chronic) pancolitis

16.5

323.0

570

353

WZA10

NOMESCO Finland

Long statement of health and health related matters

10.3

323.0

881

879

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

13.3

323.0

1694

1356

M08.0

ICD-10 Finland

Juvenile rheumatoid arthritis

56.6

323.0

538

TPH04

NOMESCO Finland

Cathetrisation of vein

2.1

323.0

5550

29766

M25.5

ICD-10 Finland

Pain in joint

2.0

323.0

7772

46555

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

9.7

323.0

1342

1450

K50.8

ICD-10 Finland

Other Crohn disease

31.5

323.0

1715

581

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

35.9

323.0

2489

766

NH1AE

NOMESCO Finland

Ankle joint ultrasound examination

17.3

323.0

555

328

NH3EA

NOMESCO Finland

Feet X-ray examination with load

12.6

323.0

1501

1254

TNG10

NOMESCO Finland

Puncture of knee

23.1

323.0

974

437

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.7

323.0

2740

10941

7140A

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]

32.7

323.0

986

313

L40.0

ICD-10 Finland

Psoriasis vulgaris

7.9

323.0

2532

3510

L04AB04

ATC

adalimumab; parenteral

67.3

323.0

2730

453

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

356.9

323.0

18593

1898

M01CB01

ATC

sodium aurothiomalate; parenteral

37.9

323.0

1466

409

K50.0

ICD-10 Finland

Crohn disease of small intestine

22.9

323.0

1462

676

M08.3

ICD-10 Finland

Juvenile polyarthritis (seronegative)

53.5

323.0

509

A07EC01

ATC

sulfasalazine; oral, rectal

32.4

323.0

10098

5050

M06.8

ICD-10 Finland

Other specified rheumatoid arthritis

47.8

323.0

730

157

L04AB06

ATC

golimumab; parenteral

54.8

323.0

946

179

L04AX07

ATC

dimethyl fumarate; oral

306.6

323.0

478

M45

ICD-10 Finland

Ankylosing spondylitis

10.3

323.0

1426

1458

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

50.1

323.0

2457

541

P01BA02

ATC

hydroxychloroquine; oral

29.8

323.0

9858

5269

E0000UV

ATC

1.9

323.0

10483

69353

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

3.6

323.0

1589

4580

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

64.3

323.0

7552

1652

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

65.0

323.0

4123

753

153

Kela drug reimbursment

Lenalidomid

78.1

323.0

505

TNH11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in ankle joint or foot joint

37.7

323.0

1103

305

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

12.2

323.0

728

613

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

34.0

323.0

3266

1096

A07EA02

ATC

hydrocortisone; rectal

11.3

323.0

1594

1500

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

6.6

323.0

5030

9117

R4120

NOMESCO Finland

Occupational therapy

3.1

323.0

2025

6952

M07.3

ICD-10 Finland

Other psoriatic arthropathies

45.8

323.0

1282

294

4AA12

NOMESCO Finland

118.8

323.0

421

L04AB01

ATC

etanercept; parenteral

54.5

323.0

1897

375

K50.1

ICD-10 Finland

Crohn disease of large intestine

29.5

323.0

1286

458

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

37.6

323.0

1402

394

L04AA11

ATC

[U] etanercept; parenteral

45.8

323.0

420

L04AA24

ATC

abatacept; parenteral

72.1

323.0

427

H02AB06

ATC

prednisolone; systemic

8.7

323.0

20179

76896

N02AX02

ATC

tramadol; systemic, rectal

1.8

323.0

10343

71390

UJF30

NOMESCO Finland

Ileoscopy through colon

3.9

323.0

3816

11025

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

75.1

323.0

937

129

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.7

323.0

10516

73700

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

24.3

323.0

7731

4469

M13.9

ICD-10 Finland

Arthritis, unspecified

8.6

323.0

4704

6532

L04AX01

ATC

azathioprine; systemic

124.8

323.0

7768

890

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

26.7

323.0

7906

4209

L40.5

ICD-10 Finland

Arthropathic psoriasis

37.3

323.0

1937

560

UJF32

NOMESCO Finland

Coloscopy

2.6

323.0

7817

37108

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

15.5

323.0

1601

1094

TNG11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in knee

24.7

323.0

716

298

M05

ICD-10 Finland

Seropositive rheumatoid arthritis

65.6

323.0

931

147

J01DB01

ATC

cefalexin; oral

1.8

323.0

20602

177273

D05AX02

ATC

calcipotriol; topical

5.9

323.0

1855

3315

L88

ICPC

Rheumatoid/seropositive arthritis

46.0

323.0

4957

1328

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

11.6

323.0

2328

2185

L04AA13

ATC

leflunomide; oral

54.1

323.0

3289

696

L04AX04

ATC

lenalidomide; oral

134.6

323.0

502

L01BB02

ATC

mercaptopurine; oral

78.6

323.0

1333

179

K51.8

ICD-10 Finland

Other ulcerative colitis

13.9

323.0

1020

762

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

10.0

323.0

1189

1243

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

5.8

323.0

3290

6313

L04AB05

ATC

certolizumab pegol; parenteral

62.9

323.0

482

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

10.6

323.0

1643

1646

M06

ICD-10 Finland

Other rheumatoid arthritis

44.0

323.0

574

133

L04AD01

ATC

ciclosporin; systemic

18.0

323.0

1684

994

ZX120

NOMESCO Finland

Intravenous

4.6

323.0

4190

10405

K51.5

ICD-10 Finland

Left sided colitis

16.6

323.0

2485

1644

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

4.8

323.0

3885

9215

ZX140

NOMESCO Finland

Intra articular

16.3

323.0

584

366

NK5AT

NOMESCO Finland

Joint injection with ultrasound guidance not elsewhere classified

19.1

323.0

563

301

D05AX52

ATC

calcipotriol, combinations; topical

5.9

323.0

2756

5153

K50.9

ICD-10 Finland

Crohn disease, unspecified

22.2

323.0

1413

671

D07AC01

ATC

betamethasone; topical

1.8

323.0

8587

55941

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

3.0

323.0

2972

10658

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

5.7

323.0

1673

3083

TNB11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in shoulder joint

26.5

323.0

485

186

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.4

323.0

3185

14391

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.0

323.0

7467

43388

D05BB02

ATC

acitretin; oral

8.0

323.0

1189

1549

L04AC05

ATC

ustekinumab; parenteral

74.2

323.0

430

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.4

323.0

14196

69054

M13.0

ICD-10 Finland

Polyarthritis, unspecified

10.1

323.0

679

691

4AB02

NOMESCO Finland

154.3

323.0

485

A07EC02

ATC

mesalazine; oral, rectal

10.4

323.0

4155

4688

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

4.2

323.0

1486

3664

H02AB04

ATC

methylprednisolone; systemic

2.6

323.0

4537

19563

M08.4

ICD-10 Finland

Pauciarticular juvenile arthritis

46.0

323.0

555

123

71238

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita

23.6

323.0

535

231

H02AB07

ATC

prednisone; oral

4.5

323.0

6288

17393

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

17.8

323.0

524

300

D07AD01

ATC

clobetasol; topical

2.2

323.0

4340

21489

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

76.0

323.0

5891

1002

M05BA04

ATC

alendronic acid; oral

4.4

323.0

2967

7477

L04AA06

ATC

mycophenolic acid; systemic

7.8

323.0

926

1228

XX9XE

NOMESCO Finland

Other ultrasound examination

17.7

323.0

693

401

D07XC01

ATC

betamethasone, combinations; topical

2.9

323.0

3828

14715

M01CB03

ATC

auranofin; oral

23.8

323.0

622

267

L04AA01

ATC

[U] ciclosporin; systemic

24.7

323.0

1397

597

K51.1

ICD-10 Finland

Ulcerative (chronic) ileocolitis

22.7

323.0

894

407

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

65.2

323.0

3880

699

M01AH01

ATC

celecoxib; oral (coxibs)

2.0

311.6

4669

25539

D05AX03

ATC

calcitriol; topical

8.6

309.2

703

841

L04AA17

ATC

[U] adalimumab; parenteral

56.5

307.8

368

L04AA29

ATC

tofacitinib; oral

91.5

307.0

343

NG1DA

NOMESCO Finland

X-ray of knees

6.8

305.6

814

1238

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

9.6

304.7

646

685

N02BE01

ATC

paracetamol; systemic, rectal

1.8

304.6

21242

185774

L04AC10

ATC

secukinumab; parenteral

38.7

302.7

389

102

C90.0

ICD-10 Finland

Multiple myeloma

12.4

299.0

557

458

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.2

296.5

3548

17617

M35.3

ICD-10 Finland

Polymyalgia rheumatica

4.1

295.2

1226

3080

M01AC06

ATC

meloxicam; systemic, rectal

1.7

295.2

8989

62146

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.7

294.1

9554

67254

R50.9

ICD-10 Finland

Fever, unspecified

2.1

290.4

3691

18805

M01AH05

ATC

etoricoxib; oral

1.6

287.9

14472

114215

H02AB09

ATC

hydrocortisone; systemic

5.1

287.7

956

1914

K51.2

ICD-10 Finland

Ulcerative (chronic) proctitis

7.2

287.4

734

1051

3005

Kela drug reimbursment

Tofacitinib

89.2

282.9

317

J01MA02

ATC

ciprofloxacin; systemic

1.7

281.8

9040

63192

E000001

ATC

1.9

279.7

5311

31546

H20.1

ICD-10 Finland

Chronic iridocyclitis

9.4

279.1

601

655

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

6.9

275.7

724

1078

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

5.7

273.0

825

1477

R4110

NOMESCO Finland

Physiotherapy

1.8

272.4

6525

41771

329

Kela drug reimbursment

Lenalidomide

69.8

268.9

311

UJF92

NOMESCO Finland

Capsular endoscopy

5.3

268.3

866

1676

NHG76

NOMESCO Finland

Arthroplasty of other tarsometatarsal joint

7.1

265.8

679

972

291

Kela drug reimbursment

Tofacitinib

101.8

264.7

292

NDG30

NOMESCO Finland

Fusion of wrist, total

21.5

263.7

396

187

127

Kela drug reimbursment

Transplant complication

6.6

262.4

713

1113

NDL52

NOMESCO Finland

Tenosynovectomy of hand

15.3

262.2

445

295

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

8.2

261.7

609

756

L04AC07

ATC

tocilizumab; parenteral

75.4

260.4

298

L04AX05

ATC

pirfenidone; oral

154.3

259.2

275

157

Kela drug reimbursment

Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)

9.8

256.2

537

557

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

7.2

253.0

643

913

L01BB01

ATC

188.9

250.8

262

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.4

248.9

2405

10725

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.9

248.4

4096

23007

K51

ICD-10 Finland

Ulcerative colitis

10.0

247.8

515

526

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

245.4

11052

83434

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

19.4

245.3

381

199

NF1AA

NOMESCO Finland

Hip X-ray examination

2.5

244.1

2118

8927

109

Kela drug reimbursment

Multiple sclerosis

7.8

242.8

583

760

J01FF01

ATC

clindamycin; systemic

1.7

242.5

6590

43509

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.8

239.5

4907

29682

303

Kela drug reimbursment

Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)

8.8

238.9

532

614

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.8

236.9

1690

6359

M05BA07

ATC

risedronic acid; oral

4.1

232.1

967

2429

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

231.2

9013

65353

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.3

228.1

2443

11431

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

3.5

227.3

1128

3290

71239

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides NUD

14.3

225.0

392

277

7140B

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SERONEGATIVA]

23.2

224.0

328

143

D07AC13

ATC

mometasone; topical

1.6

223.4

6890

46912

TNC11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in elbow joint

42.3

223.1

281

JF1DG

NOMESCO Finland

Small bowel very extensive MRI with with high intensity magnet

22.0

222.8

332

153

M02.9

ICD-10 Finland

Reactive arthropathy, unspecified

6.0

221.6

641

1085

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

3.6

219.4

1082

3139

WX002

NOMESCO Finland

Sedation and analgesia

1.8

219.3

4652

28353

WZC30

NOMESCO Finland

Teaching

2.0

219.1

3280

17684

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.4

218.8

2124

9464

TND10

NOMESCO Finland

Joint puncture, wrist or finger joint

39.2

217.9

279

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.6

213.8

1740

7061

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

10.4

213.3

433

423

3006

Kela drug reimbursment

Baricitinib

83.2

211.7

239

G35

ICD-10 Finland

Multiple sclerosis

5.5

211.4

662

1235

L20

ICPC

Joint symptom/complaint NOS

3.4

208.2

1103

3382

D94

ICPC

Chronic enteritis/ulcerative colitis

11.5

207.8

400

352

M13.8

ICD-10 Finland

Other specified arthritis

8.6

207.6

468

551

K73.2

ICD-10 Finland

Chronic active hepatitis, not elsewhere classified

22.7

206.9

305

136

M46.1

ICD-10 Finland

Sacroiliitis, not elsewhere classified

6.4

206.2

571

913

M31.3

ICD-10 Finland

Wegener granulomatosis

29.8

205.1

280

TQW80

NOMESCO Finland

Local dermatologic skincare

4.0

203.6

857

2170

293

Kela drug reimbursment

Baricitinib

91.6

203.4

227

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

3.8

203.2

923

2500

A02BC03

ATC

lansoprazole; oral

1.6

202.8

6658

45844

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.9

201.8

1331

4754

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

5.0

201.0

686

1410

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

4.7

200.2

719

1560

284

Kela drug reimbursment

Nintedanib and pirfenidone

26.0

198.6

281

109

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.5

198.5

1757

7452

M06.4

ICD-10 Finland

Inflammatory polyarthropathy

23.3

197.0

288

125

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

15.0

194.8

333

225

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

3.2

194.0

1102

3553

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.3

194.0

2063

9585

L40.9

ICD-10 Finland

Psoriasis, unspecified

5.9

193.8

571

989

S91

ICPC

Psoriasis

9.5

193.7

412

439

N07XX09

ATC

[U] dimethyl fumarate; oral

43.0

193.6

243

K50

ICD-10 Finland

Crohn disease [regional enteritis]

22.9

192.5

283

125

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.8

189.9

4171

25556

L04AA37

ATC

baricitinib; oral

77.8

189.7

216

J05AB11

ATC

valaciclovir; oral

1.9

189.3

3211

18052

377

Kela drug reimbursment

Apremilast and dimethyl fumarate (psoriasis)

33.3

183.9

244

J01MA12

ATC

levofloxacin; systemic

1.7

183.6

4082

25079

WW200

NOMESCO Finland

Immunization

3.5

182.8

902

2613

XW000

NOMESCO Finland

Bone marrow biopsy

3.1

182.5

1088

3628

RT272

NOMESCO Finland

21.8

182.3

272

126

M35.1

ICD-10 Finland

Other overlap syndromes

15.6

181.3

305

198

TGC00

NOMESCO Finland

Bronchial lavation

3.9

181.3

786

2042

M07.5*K51.9

ICD-10 Finland

Arthropathy in ulcerative colitis

29.4

181.3

248

L40

ICD-10 Finland

Psoriasis

4.9

181.3

627

1307

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

5.0

179.5

605

1226

O99.6

ICD-10 Finland

Diseases of the digestive system complicating pregnancy, childbirth and the puerperium

9.9

178.8

372

381

A04AA01

ATC

ondansetron; systemic, rectal

2.4

177.7

1707

7534

B01AB05

ATC

enoxaparin; parenteral

1.6

177.6

6675

47220

H04.10

ICD-10 Finland

Dry eye syndrome

2.0

177.2

2409

12433

M07.0*L40.5

ICD-10 Finland

Distal interphalangeal psoriatic arthropathy

26.5

175.6

247

NHG77

NOMESCO Finland

Arthroplasty of interphalangeal tarsal joint(s)

4.2

175.0

708

1727

D07AB08

ATC

desonide; topical

2.0

174.7

2584

13782

H26.3

ICD-10 Finland

Drug-induced cataract

11.6

173.7

333

291

A02BC01

ATC

omeprazole; systemic

1.6

173.5

6098

42393

M07.4*K50.9

ICD-10 Finland

Arthropathy in Crohn's disease [regional enteritis]

46.8

173.5

214

P01AB01

ATC

metronidazole; oral, rectal

1.5

170.6

9197

70371

J05AB01

ATC

aciclovir; systemic

1.6

170.4

4861

32000

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

3.0

170.3

1076

3729

Z94.0

ICD-10 Finland

Kidney transplant status

6.3

169.9

476

773

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

7.6

168.3

409

543

L04AC13

ATC

ixekizumab; parenteral

55.6

166.4

199

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

166.0

6401

45415

356

Kela drug reimbursment

Nintedanib and pirfenidone

26.4

165.5

233

134

Kela drug reimbursment

General erythroderma

20.0

164.4

252

127

S18

ICPC

Laceration/cut

1.5

162.7

9277

71595

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.5

159.9

6773

49015

NH3AE

NOMESCO Finland

Feet ultrasound examination

23.6

159.6

232

M05BX04

ATC

denosumab; parenteral

2.7

158.7

1163

4423

C10AC01

ATC

colestyramine; oral

3.5

156.2

787

2316

M01AH02

ATC

rofecoxib; oral

1.8

154.9

2921

16942

M08.9

ICD-10 Finland

Juvenile arthritis, unspecified

41.7

154.7

195

D02AE01

ATC

carbamide; topical

2.2

154.1

1701

8005

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.7

153.1

723

2019

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

150.7

9321

72775

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

149.8

3828

24341

M01AE02

ATC

naproxen; oral, rectal

1.4

148.9

13364

111752

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.3

148.7

1475

6600

E000003

ATC

2.5

148.5

1217

4932

L40.8

ICD-10 Finland

Other psoriasis

7.8

147.8

355

463

ZXA00

NOMESCO Finland

Right side

1.5

147.4

5795

41084

9522

FHL

Synovectomy

29.1

147.4

202

L04AA32

ATC

apremilast; oral

32.0

147.3

197

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

3.7

145.6

668

1821

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.9

145.5

2459

13717

A02BC05

ATC

esomeprazole; systemic

1.4

145.3

9056

70656

N03AX16

ATC

pregabalin; oral

1.6

145.2

5196

36014

E000002

ATC

1.8

143.7

2733

15869

1XC02

NOMESCO Finland

8.4

142.7

326

393

NGF15

NOMESCO Finland

Total synovectomy of knee, arthroscopic

5.7

141.5

425

754

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

3.1

140.0

820

2696

H02AB08

ATC

triamcinolone; systemic

14.3

139.1

242

171

J01CA04

ATC

amoxicillin; systemic

1.5

139.0

19632

177241

TNH10

NOMESCO Finland

Joint puncture, ankle joint or foot joint

36.5

137.3

178

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.8

136.9

954

3514

NA6AA

NOMESCO Finland

Sacro-iliac joint X-ray examination

12.3

136.8

254

208

9503

FHL

Tendon or tendon sheath cleansing surgery (tenosynovectomy)

19.2

135.4

210

110

L01CB

ATC

Podophyllotoxin derivatives

29.9

135.3

184

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

135.2

4780

32958

RT271

NOMESCO Finland

27.3

134.2

187

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.9

133.8

2254

12538

M31.5

ICD-10 Finland

Giant cell arteritis with polymyalgia rheumatica

6.9

133.5

347

509

RS221

NOMESCO Finland

4.4

132.7

508

1175

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

2.6

132.4

1056

4209

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

5.0

131.6

444

901

TQW40

NOMESCO Finland

Remowal of suture of skin

2.1

131.4

1702

8565

ND1AE

NOMESCO Finland

Wrist ultrasound examination

14.8

131.0

224

152

D64.9

ICD-10 Finland

Anaemia, unspecified

2.0

129.8

1916

10151

A02BA02

ATC

ranitidine; systemic

1.6

129.7

4076

27268

C03CA01

ATC

furosemide; systemic

1.5

129.1

4917

34438

JFH30

NOMESCO Finland

Total colectomy, mucosal proctectomy and ileoanal anastomosis without ileostomy

22.9

129.0

189

B03XA01

ATC

erythropoietin; parenteral

7.6

128.3

311

412

ZX112

NOMESCO Finland

Subcutaneous

3.6

128.0

619

1762

NK4AT

NOMESCO Finland

Puncture of joint with ultrasound guidance not elsewher classified

7.6

126.0

305

403

M13.1

ICD-10 Finland

Monoarthritis, not elsewhere classified

5.6

125.6

385

700

9256

FHL

Synovectomy (knee 9311)

31.9

125.6

168

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.1

125.2

717

2319

NJ3DA

NOMESCO Finland

Long bones of extremities X-ray examination

13.1

124.3

224

172

71200

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Juvenile rheumatoid arthritis

17.9

123.4

196

110

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.5

122.9

4975

35268

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.7

122.6

876

3275

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

122.3

3434

22282

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.9

122.1

1934

10507

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

121.3

2357

13734

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.0

120.9

1627

8307

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.6

120.8

925

3600

NHM20

NOMESCO Finland

Excision of synovial ganglion of ankle or foot

5.1

120.6

395

776

SPAT1202

SPAT

Intra-articular injection

2.8

120.5

810

2914

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

3.8

118.9

532

1419

393

Kela drug reimbursment

Pomalidomide

395.8

118.6

119

WX320

NOMESCO Finland

Spinalanesthesy

1.5

117.9

4761

33687

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.0

117.8

1563

7931

SPAT1153

SPAT

Removal of sutures

1.4

117.0

6790

51718

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

12.3

116.9

217

178

R4180

NOMESCO Finland

Podiatric therapy

5.6

116.5

355

641

A07EA01

ATC

prednisolone; rectal

8.7

116.5

259

299

ZXA05

NOMESCO Finland

Left side

1.5

116.3

5260

38120

JF1BD

NOMESCO Finland

Very extensive small bowel CT

8.1

116.1

271

339

N02AA05

ATC

oxycodone; systemic

1.7

115.6

2755

17065

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.3

114.9

1159

5213

NDB78

NOMESCO Finland

Prosthetic replacement of several of finger or metacarpal

37.2

114.8

148

L99

ICPC

Musculoskeletal disease other

3.6

114.6

544

1525

NDF60

NOMESCO Finland

Operation for osteochondritis of a joint of hand,v

14.6

113.6

195

134

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

5.7

113.4

342

610

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.0

113.4

1491

7537

L04AC16

ATC

guselkumab; systemic

58.5

113.2

134

B07.9

ICD-10 Finland

Verruca simplex

2.6

113.0

884

3483

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.1

112.6

1312

6304

NHG24

NOMESCO Finland

Fusion of subtalar joint and between bones of ankle

7.6

111.5

271

361

3AC01

NOMESCO Finland

5.1

110.5

365

724

RK220

NOMESCO Finland

11.8

109.9

208

178

P01BA01

ATC

chloroquine; systemic

9.6

109.6

231

243

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.4

109.5

7389

57685

L04AX06

ATC

pomalidomide; oral

+∞

109.4

105

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

6.7

109.1

287

429

M07.0

ICD-10 Finland

Distal interphalangeal psoriatic arthropathy

28.4

109.1

150

M05BB03

ATC

alendronic acid and colecalciferol; oral

3.4

108.0

553

1647

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.7

107.7

2255

13420

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.7

107.6

2674

16738

K07.65

ICD-10 Finland

Temporomandibular joint-pain-dysfunction syndrome

5.4

107.0

336

629

L01AA01

ATC

cyclophosphamide; systemic

12.7

106.6

195

155

1507

Kela drug reimbursment

Pomalidomide

355.3

106.3

107

7151

FHL

Kidney transplantation

91.2

106.0

118

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

3.3

105.8

561

1715

M01AX17

ATC

nimesulide; oral

1.5

105.7

5062

37007

S01BA01

ATC

dexamethasone; ophthalmic (corticosteroids, plain)

2.5

105.6

873

3545

9284

FHL

Wrist ossification surgery

41.4

104.8

132

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

2.0

104.2

1439

7408

TAB00

NOMESCO Finland

Lumbar puncture

2.3

103.9

1068

4840

K75.4

ICD-10 Finland

Autoimmune hepatitis

23.3

103.9

151

D02AX

ATC

Other emollients and protectives

2.5

103.6

850

3438

7143C

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Juvenile chronic polyarthritis[POLYARTHRITIS JUVENILIS SERONEGATIVA]

39.9

103.2

131

XQ848

NOMESCO Finland

Dermatological photography

3.0

102.8

644

2214

WW300

NOMESCO Finland

Transfer of autologic stem cells

10.0

102.8

211

212

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.9

101.8

1641

8950

NDF10

NOMESCO Finland

Synovectomy of wrist

22.7

101.6

149

PAW37

NOMESCO Finland

Biopsy of temporal artery

7.1

101.5

257

364

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

101.4

8807

71478

SPAT1325

SPAT

Vaccination

1.4

101.2

7138

55972

4AA33

NOMESCO Finland

52.8

100.6

121

M05.3

ICD-10 Finland

Rheumatoid arthritis with involvement of other organs and systems

46.1

100.6

124

A05AA02

ATC

ursodeoxycholic acid; oral

3.6

99.9

479

1354

J01MA14

ATC

moxifloxacin; systemic

1.8

99.6

1860

10664

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

11.4

99.6

191

168

318

Kela drug reimbursment

Teriparatide

9.2

99.2

214

235

C91.0

ICD-10 Finland

Acute lymphoblastic leukaemia [ALL]

14.6

99.1

170

117

M12.3

ICD-10 Finland

Palindromic rheumatism

14.8

98.9

169

115

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.2

98.6

1040

4773

M01AB55

ATC

diclofenac, combinations; oral

1.9

98.5

1452

7661

NCF10

NOMESCO Finland

Synovectomy of elbow joint, open

39.3

98.2

125

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.7

98.0

2435

15215

XPX04

NOMESCO Finland

Angioscopy

9.0

97.8

213

238

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

97.8

5823

44273

NDB60

NOMESCO Finland

Prosthetic replacement of MCP joint of finger

28.6

97.7

134

O99.89

ICD-10 Finland

Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

3.6

97.3

466

1316

B02.9

ICD-10 Finland

Zoster without complication

2.1

97.3

1184

5786

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.3

97.1

977

4383

M33.2

ICD-10 Finland

Polymyositis

22.3

96.4

142

M17.5

ICD-10 Finland

Other secondary gonarthrosis

4.2

96.3

381

910

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

5.8

96.2

285

498

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.5

95.9

3643

25291

RT310

NOMESCO Finland

40.4

95.7

121

N03AX12

ATC

gabapentin; oral

1.5

95.7

3216

21706

S01BA04

ATC

prednisolone; ophthalmic (corticosteroids, plain)

3.1

94.9

555

1821

3042

Kela drug reimbursment

43.8

94.9

118

N08.5*M31.3

ICD-10 Finland

Glomerular disorders in Wegener's granulomatosis

40.2

94.8

120

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.6

94.7

2577

16496

M34.1

ICD-10 Finland

CR(E)ST syndrome

9.6

94.7

199

209

253

Kela drug reimbursment

45.1

94.6

117

NF2AT

NOMESCO Finland

Injection to hip joint with ultrasound guidance

7.6

94.5

229

304

NDG74

NOMESCO Finland

Fusion of first IP joint

13.8

94.4

166

121

M81.4

ICD-10 Finland

Drug-induced osteoporosis

10.6

94.1

187

177

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

94.0

9903

82493

NF1DA

NOMESCO Finland

X-ray of hips

3.1

93.8

549

1803

5BA08

NOMESCO Finland

8.0

93.5

219

276

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

93.4

8734

71437

WX204

NOMESCO Finland

Axillary plexus blockaced

2.5

93.4

758

3046

RK210

NOMESCO Finland

14.8

93.2

159

108

M06.3

ICD-10 Finland

Rheumatoid nodule

43.1

93.0

116

M34.9

ICD-10 Finland

Systemic sclerosis, unspecified

13.0

92.2

166

128

M32.8

ICD-10 Finland

Other forms of systemic lupus erythematosus

15.9

91.7

152

NHG22

NOMESCO Finland

Fusion of subtalar joint

6.5

91.6

248

386

A07EC03

ATC

olsalazine; oral

16.9

91.4

148

L34

ICPC

Musculoskeletal, Blood test

54.7

91.2

109

M01AX01

ATC

nabumetone; oral

2.2

90.9

983

4561

S97

ICPC

Chronic ulcer skin

2.1

90.8

1048

5003

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

4.0

90.8

379

952

ZZH31

NOMESCO Finland

Bone allograft, small pieces

5.7

90.7

273

487

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

3.2

90.7

509

1623

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.7

90.5

2248

14027

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.9

90.3

1340

7084

R1250

NOMESCO Finland

Evaluation of functional capability

3.0

90.0

557

1898

137

Kela drug reimbursment

Uraemia requiring dialysis

5.2

90.0

289

556

SPAT1255

SPAT

Intravenous administration of medicine

1.9

89.4

1353

7204

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.6

89.0

700

2762

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

89.0

4744

35239

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

88.8

15048

133614

J01DA01

ATC

[U] cefalexin; systemic

1.3

88.2

14113

124262

H05AA02

ATC

teriparatide; parenteral

8.8

88.2

194

221

6960A

ICD-9 Finland

Psoriasis and similar disorders, Psoriatic arthropathy

18.5

88.1

138

ZXA10

NOMESCO Finland

Bilateral

1.5

88.0

3739

26540

L04AC14

ATC

sarilumab; systemic

82.8

88.0

J01FA06

ATC

roxithromycin; oral

1.3

87.2

8707

71703

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

86.9

4097

29700

H22.1*M45

ICD-10 Finland

Iridocyclitis in ankylosing spondylitis

22.2

86.8

128

M01CC01

ATC

penicillamine; oral

22.2

86.8

128

L03AB07

ATC

interferon beta-1a; parenteral

6.4

86.7

235

367

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.9

86.5

568

2012

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.7

85.9

1914

11572

E000007

ATC

1.9

85.9

1270

6701

Z71.8

ICD-10 Finland

Other specified counselling

1.4

85.8

5110

38697

A12AA04

ATC

calcium carbonate; oral

3.7

85.7

399

1102

M05BA06

ATC

ibandronic acid; systemic

3.3

85.7

451

1372

M07.5

ICD-10 Finland

Arthropathy in ulcerative colitis

39.1

85.7

109

L28

ICPC

Limited function/disability (L)

1.5

85.2

2831

19013

J01AA02

ATC

doxycycline; systemic

1.3

85.1

17777

161994

L17

ICPC

Foot/toe symptom/complaint

1.4

84.9

5184

39418

A46

ICD-10 Finland

Erysipelas

1.6

84.6

2581

16979

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

4.5

84.2

311

696

ZX108

NOMESCO Finland

Inhalation

5.6

84.1

255

459

TNF11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in hip joint

19.6

84.1

129

WX110

NOMESCO Finland

Local anesthesy

1.3

83.7

16000

143787

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.5

83.7

2779

18654

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

9.6

83.6

175

183

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.3

83.0

6554

51979

RJ411

NOMESCO Finland

6.8

82.9

215

316

L40.3

ICD-10 Finland

Pustulosis palmaris et plantaris

3.5

82.5

408

1183

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

82.5

6557

52051

SPAT1263

SPAT

Sampling

1.3

82.3

9236

77154

WZA90

NOMESCO Finland

Other doctors statement

1.4

82.2

4997

37935

SPAT1229

SPAT

Assessment of need for aid

1.8

81.8

1477

8356

RJ421

NOMESCO Finland

9.1

81.8

177

196

M07.2*L40.5

ICD-10 Finland

Psoriatic spondylitis

23.0

81.7

119

NCB20

NOMESCO Finland

Primary total prosthetic replacement of elbow joint

21.7

81.6

121

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.7

81.6

1672

9849

NA6CG

NOMESCO Finland

Sacro-iliac joint extensive MRI examination with high intensity magnet

7.1

81.4

205

289

A11CC03

ATC

alfacalcidol; systemic

2.9

81.0

528

1863

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.0

80.9

1081

5481

NHG82

NOMESCO Finland

Fusion of other tarsal joint

4.6

80.9

292

638

R2110

NOMESCO Finland

Giving the first information

1.8

80.6

1540

8876

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

80.5

11501

99183

XG410

NOMESCO Finland

Flow-volume spirometry

2.2

80.4

896

4209

3029

Kela drug reimbursment

Upadacitinib

98.1

79.9

L04AX02

ATC

thalidomide; oral

98.1

79.9

C08CA05

ATC

nifedipine; systemic

1.9

79.8

1206

6412

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.6

79.5

2169

13855

M79.6

ICD-10 Finland

Pain in limb

1.3

79.5

7477

60814

L01AA03

ATC

melphalan; systemic

29.3

79.4

108

J99.1*M31.3

ICD-10 Finland

Respiratory disorders in Wegener's granulomatosis

39.0

79.4

101

D05AA

ATC

Tars

6.2

79.2

220

355

M08.8

ICD-10 Finland

Other juvenile arthritis

75.3

79.1

M32.1

ICD-10 Finland

Systemic lupus erythematosus with organ or system involvement

19.6

78.9

121

R06.0

ICD-10 Finland

Dyspnoea

1.4

78.6

4796

36384

N08.5

ICD-10 Finland

Glomerular disorders in systemic connective tissue disorders

22.0

78.6

116

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

2.0

78.1

1123

5860

J01FA10

ATC

azithromycin; systemic

1.3

78.1

13366

117808

M19.2

ICD-10 Finland

Other secondary arthrosis

3.8

78.0

347

923

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.0

77.8

1122

5862

7143D

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Juvenile chronic polyarthritis[OLIGARTHRITIS JUVENILIS]

28.7

77.6

106

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

77.4

4707

35677

M05BA01

ATC

etidronic acid; systemic

7.6

77.4

186

245

NDF68

NOMESCO Finland

Operation for osteochondritis of several joints of hand, open

40.5

76.9

A07AA02

ATC

nystatin; oral

1.9

76.9

1244

6775

RT171

NOMESCO Finland

16.8

76.6

124

RD210

NOMESCO Finland

2.9

76.6

490

1708

M04AA01

ATC

allopurinol; systemic

1.6

76.3

2109

13510

NB2AT

NOMESCO Finland

Intra artrial injection of shoulder with ultrasound guidance

3.6

76.3

361

1011

E000006

ATC

1.8

76.3

1494

8672

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

3.4

76.1

391

1169

NG2CA

NOMESCO Finland

X-ray of patella with specialised projection

7.0

75.6

193

278

M07.4

ICD-10 Finland

Arthropathy in Crohn disease [regional enteritis]

42.8

75.4

5552A

ICD-9 Finland

Regional enteritis, Small intestine with large intestine

35.1

75.3

398

Kela drug reimbursment

Ixazomib

740.2

75.2

H46

ICD-10 Finland

Optic neuritis

4.6

75.1

274

606

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.5

74.8

2759

18935

GD1AD

NOMESCO Finland

Thorax CT examination

2.1

74.7

855

4062

299

Kela drug reimbursment

52.5

74.1

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.9

74.1

1086

5705

K83.0

ICD-10 Finland

Cholangitis

3.7

74.0

340

930

RF410

NOMESCO Finland

3.7

73.7

336

913

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.5

73.4

593

2377

Z94.4

ICD-10 Finland

Liver transplant status

8.5

73.3

164

193

WX203

NOMESCO Finland

Infraclavicular plexus blockade

2.6

73.2

555

2145

9835/3-C42.1

ICD-O-3

Precursor cell lymphoblastic leukemia, NOS, of bone marrow

23.1

73.0

106

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.7

72.9

1486

8728

D06BB04

ATC

podophyllotoxin; topical

1.9

72.3

1142

6168

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

3.0

72.3

446

1520

G70.0

ICD-10 Finland

Myasthenia gravis

8.2

72.0

165

202

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.9

71.8

1062

5599

K02.1

ICD-10 Finland

Caries of dentine

1.3

71.4

12892

113799

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.1

71.4

866

4219

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.9

71.3

1068

5657

7200A

ICD-9 Finland

Ankylosing spondylitis and other inflammatory spondylopathies, Ankylosing spondylitis

8.5

71.1

160

190

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.7

71.1

1462

8609

1505

Kela drug reimbursment

Ixazomib

699.9

71.1

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

4.4

71.0

271

627

RS222

NOMESCO Finland

3.7

71.0

326

891

NDG76

NOMESCO Finland

Fusion of DIP joint

4.7

71.0

253

547

M05.0

ICD-10 Finland

Felty syndrome

23.0

70.8

103

J02AC01

ATC

fluconazole; systemic

1.3

70.3

8692

73098

AA1AA

NOMESCO Finland

Head X-ray examination

4.9

70.0

236

481

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.3

69.4

7513

62039

1XX32

NOMESCO Finland

37.2

69.4

K07.60

ICD-10 Finland

Snapping jaw

1.9

69.2

1081

5812

M08.1

ICD-10 Finland

Juvenile ankylosing spondylitis

34.7

69.1

JFB20

NOMESCO Finland

Ileocaecal resection

6.5

69.1

186

289

L95

ICPC

Osteoporosis

2.4

68.9

605

2534

L40.4

ICD-10 Finland

Guttate psoriasis

6.9

68.9

178

261

L03AX13

ATC

glatiramer acetate; parenteral

6.5

68.7

184

284

NGB40

NOMESCO Finland

Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis

2.6

68.6

542

2147

M31.1

ICD-10 Finland

Thrombotic microangiopathy

24.0

68.3

RS121

NOMESCO Finland

5.3

68.1

215

407

K71

ICPC

Rheumatic fever/heart disease

37.9

68.1

ND2AE

NOMESCO Finland

Hand and fingers ultrasound examination

13.2

67.8

121

298

Kela drug reimbursment

106.0

67.8

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.0

67.6

409

1374

R06AE07

ATC

cetirizine; oral

1.3

67.4

9593

81997

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.5

67.0

2573

17793

69619

ICD-8 Finland

Psoriasis and similar disorders, Psoriasis alia sive NUD (vulgaris)

7.9

66.6

156

198

JF1AD

NOMESCO Finland

Small bowel CT

6.2

66.5

185

300

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

2.3

66.5

647

2855

9272

FHL

Metatarsophalangeal joint resection

9.7

66.4

138

143

JFG00

NOMESCO Finland

Closure of loop enterostomy without resection

5.9

66.3

192

328

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

2.4

66.2

599

2549

RF420

NOMESCO Finland

3.2

66.1

359

1120

G37.9

ICD-10 Finland

Demyelinating disease of central nervous system, unspecified

4.7

65.9

233

500

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.7

65.8

480

1815

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

7.1

65.7

166

236

EG1CG

NOMESCO Finland

Extensive MRI examination of mandipular joint with high intensity magnet

8.9

65.4

143

162

9527

FHL

Alloarthroplasty, implant or endoprosthesis

33.2

65.3

108

Kela drug reimbursment

Myasthenia gravis

9.1

64.9

140

155

B03BA03

ATC

hydroxocobalamin; parenteral

1.9

64.8

983

5227

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

4.1

64.8

263

646

2AB04

NOMESCO Finland

11.0

64.4

125

114

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

2.6

64.4

501

1968

RF120

NOMESCO Finland

3.5

64.3

312

893

M00.9

ICD-10 Finland

Pyogenic arthritis, unspecified

3.8

64.3

284

752

R60.0

ICD-10 Finland

Localized oedema

1.6

64.1

1988

13083

RJ511

NOMESCO Finland

13.0

64.0

115

L88

ICD-10 Finland

Pyoderma gangrenosum

13.0

64.0

115

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.3

63.9

11850

104318

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.3

63.7

594

2566

A03FA01

ATC

metoclopramide; systemic, rectal

1.4

63.7

4125

31467

R03AC02

ATC

salbutamol; inhalant

1.3

63.5

11493

100862

NG1EA

NOMESCO Finland

Knee X-ray examination with wrench

3.3

63.5

333

1013

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

2.8

63.3

418

1488

I41.8*D86.8

ICD-10 Finland

Sarcoid myocarditis

10.6

63.3

125

118

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

63.1

5718

45924

L11

ICPC

Wrist symptom/complaint

1.6

63.0

1608

10066

TQW99

NOMESCO Finland

Other minor procedure on skin

1.9

62.8

928

4887

5550A

ICD-9 Finland

Regional enteritis, Small intestine

34.2

62.8

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.4

62.3

4307

33192

RJ410

NOMESCO Finland

6.8

62.3

161

237

NDC40

NOMESCO Finland

Secondary prosthetic replacement in of joint of finger or metacarpal

36.4

62.2

L84

ICD-10 Finland

Corns and callosities

2.2

62.0

676

3146

4AA24

NOMESCO Finland

78.0

62.0

7148X

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Other specified inflammatory polyarthropathies

16.3

61.9

101

L04AA44

ATC

upadacitinib; oral

132.2

61.8

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.5

61.7

2391

16542

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

61.7

4678

36572

JFA38

NOMESCO Finland

Endoscopic dilatation of small intestine

34.9

61.5

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.5

61.1

2197

14956

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

3.4

61.1

315

946

M02AA07

ATC

piroxicam; topical

1.3

61.0

7242

60283

R5120

NOMESCO Finland

Preparation of an aid

2.5

60.7

492

1978

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.8

60.5

1142

6540

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.0

60.2

785

3940

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.5

60.2

498

2023

M79.7

ICD-10 Finland

Fibromyalgia

2.1

59.9

714

3452

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

59.9

7612

63879

B03XA02

ATC

darbepoetin alfa; parenteral

2.9

59.0

378

1321

M33.9

ICD-10 Finland

Dermatopolymyositis, unspecified

19.0

59.0

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

5.6

58.9

177

317

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

3.0

58.6

361

1231

L12.0

ICD-10 Finland

Bullous pemphigoid

6.2

58.5

162

262

WX2DD

NOMESCO Finland

Low-dose CT of skeleton in whole body

13.2

58.5

104

M17.4

ICD-10 Finland

Other secondary gonarthrosis, bilateral

6.8

58.2

150

220

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

1.8

58.2

988

5464

XF400

NOMESCO Finland

ECG with 12 standard connections

1.4

58.2

2970

21697

M33.1

ICD-10 Finland

Other dermatomyositis

21.6

58.1

L12

ICPC

Hand/finger symptom/complaint

1.4

58.1

2836

20544

4AC07

NOMESCO Finland

50.1

58.0

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.7

57.7

1355

8286

Z50.1

ICD-10 Finland

Other physical therapy

1.8

57.5

1073

6124

M31.7

ICD-10 Finland

Microscopic polyangiitis

24.2

57.4

H25.1

ICD-10 Finland

Senile nuclear cataract

1.4

57.4

3715

28279

JFH11

NOMESCO Finland

Laparoscopic colectomy

35.3

57.1

N07AA02

ATC

pyridostigmine; systemic

5.8

56.9

167

291

TK800

NOMESCO Finland

Hemodialysis

2.5

56.5

452

1804

Z01.2

ICD-10 Finland

Dental examination

1.2

56.4

8989

77360

M31.9

ICD-10 Finland

Necrotizing vasculopathy, unspecified

11.7

56.3

106

NDU20

NOMESCO Finland

Removal of internal fixation device from wrist or hand

2.5

56.3

479

1974

S01CA02

ATC

prednisolone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

3.3

56.2

293

888

JH1CG

NOMESCO Finland

Extensive MRI of perianal area

5.8

56.2

165

288

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

2.1

56.1

653

3125

M32.0

ICD-10 Finland

Drug-induced systemic lupus erythematosus

12.3

56.1

103

H20.9

ICD-10 Finland

Iridocyclitis, unspecified

3.6

56.1

266

749

ACC51

NOMESCO Finland

Release of median nerve

1.6

56.0

1430

8946

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.3

56.0

531

2314

R05

ICD-10 Finland

Cough

1.4

55.9

3793

29084

B05DA

ATC

Isotonic solutions

4.5

55.5

203

452

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.2

55.4

12758

114272

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.6

55.4

1575

10133

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.5

55.2

2421

17167

JFA58

NOMESCO Finland

Endoscopic dilatation of colon

9.9

55.1

113

115

6961A

ICD-9 Finland

Psoriasis and similar disorders, Other psoriasis[PSORIASIS VULGARIS]

9.0

54.8

118

131

M06.1

ICD-10 Finland

Adult-onset Still disease

21.4

54.7

H30.2

ICD-10 Finland

Posterior cyclitis

8.6

54.6

121

141

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.4

54.4

492

2094

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.5

54.3

1918

12986

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.7

54.2

1116

6565

SAA01

NOMESCO Finland

Simple examination of mouth

1.2

54.2

16152

148567

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.2

54.2

573

2631

L04AA33

ATC

vedolizumab; parenteral

50.1

53.9

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

5.4

53.6

165

305

A07AA09

ATC

vancomycin; oral

3.3

53.6

284

872

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

4.9

53.4

182

377

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.4

53.4

486

2078

-1

NOMESCO Finland

1.3

53.3

7192

60588

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.4

53.3

3030

22540

602

Kela drug reimbursment

Children's severe malnutrition

7.9

53.2

124

157

4AB0M

NOMESCO Finland

271.5

53.1

7143B

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Juvenile chronic polyarthritis[POLYARTHRITIS JUVENILIS SEROPOSITIVA]

39.5

53.1

A41.9

ICD-10 Finland

Sepsis, unspecified

2.1

53.0

626

3017

M66.0

ICD-10 Finland

Rupture of popliteal cyst

3.1

52.9

304

989

S01FA04

ATC

cyclopentolate; ophthalmic

3.4

52.8

269

802

NK6MA

NOMESCO Finland

Measurement of bone age from hand and elbow using X-ray

4.4

52.6

196

445

WW500

NOMESCO Finland

Blood transfusion

2.0

52.6

742

3841

N86

ICPC

Multiple sclerosis

4.5

52.5

192

428

TNB10

NOMESCO Finland

Joint puncture, shoulder joint

9.9

52.4

107

108

M02.8

ICD-10 Finland

Other reactive arthropathies

5.7

52.4

155

273

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.4

52.2

2972

22106

M01AB01

ATC

indometacin; systemic, rectal

1.6

52.1

1291

8006

H26.2

ICD-10 Finland

Complicated cataract

3.2

51.4

284

899

RJ512

NOMESCO Finland

12.6

51.3

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.2

51.3

547

2519

SPAT1301

SPAT

No procedures

1.3

51.3

6316

52566

NHB10

NOMESCO Finland

Primary partial prosthetic replacement of ankle joint

11.0

51.2

5568X

ICD-9 Finland

Idiopathic proctocolitis, Other ulcerative colitis

9.6

50.9

106

111

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

3.4

50.9

260

777

132

Kela drug reimbursment

Sarcoidosis

4.5

50.7

186

416

K60.3

ICD-10 Finland

Anal fistula

2.6

50.7

386

1497

A28

ICPC

Limited function/disability NOS

1.4

50.7

2291

16326

5562A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) proctitis

8.2

50.6

115

140

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

2.3

50.5

472

2044

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.7

50.4

1890

26166

M46.8

ICD-10 Finland

Other specified inflammatory spondylopathies

11.3

50.4

9531

FHL

Arthrodesis of the hand joint

6.5

50.1

134

208

9311

FHL

Knee cleansing surgery (synovectomy, debridement)

10.7

49.9

M43.4

ICD-10 Finland

Other recurrent atlantoaxial subluxation

18.2

49.9

NDL66

NOMESCO Finland

Transposition of tendon of wrist or hand, other tendon

6.0

49.9

141

235

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

49.7

1358

8641

5561A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) ileocolitis

7.9

49.6

116

148

WVA20

NOMESCO Finland

Medicine administration

2.4

49.3

447

1907

D05AX05

ATC

tazarotene; topical

10.8

49.2

9289

FHL

Other measure in this category

17.4

49.1

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

1.9

49.1

777

4196

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

3.2

48.9

263

817

SBA10

NOMESCO Finland

Measurement of excretion of saliva

3.3

48.9

254

769

D47.2

ICD-10 Finland

Monoclonal gammopathy of undetermined significance (MGUS)

3.5

48.8

239

692

M25.4

ICD-10 Finland

Effusion of joint

3.0

48.7

298

1013

7100A

ICD-9 Finland

Diffuse diseases of connective tissue, Systemic lupus erythematosus

15.0

48.3

NHM99

NOMESCO Finland

Other operation on fascia, ganglion, synovial sheath or bursa of ankle or foot

4.3

48.2

183

424

JHA00

NOMESCO Finland

Anal or perianal incision

2.9

48.2

311

1095

M35.7

ICD-10 Finland

Hypermobility syndrome

2.8

48.1

317

1128

J01FA09

ATC

clarithromycin; systemic

1.3

48.0

6602

55582

JN3AD

NOMESCO Finland

Abdominal CT examination

1.6

48.0

1372

8833

JX1LA

NOMESCO Finland

Kinetic X-ray of alimentary tract with pictures

11.4

48.0

R4190

NOMESCO Finland

Nutritional therapy

1.9

48.0

701

3677

SAA04

NOMESCO Finland

Special inverstigation of mouth

1.7

47.9

1122

6852

M16.7

ICD-10 Finland

Other secondary coxarthrosis

3.9

47.8

206

536

JFH33

NOMESCO Finland

Total colectomy, mucosal proctectomy, ileoanal anastomosis and ileostomy

17.3

47.8

1370

FHL

Colonoscopy, whole colon

5.3

47.8

149

280

D07AA02

ATC

hydrocortisone; topical

1.4

47.8

2712

20139

QC6S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in hand

9.1

47.5

102

113

YNB10

NOMESCO Finland

Collection of stem cells for transplant

10.5

47.5

N08.5*M31.7

ICD-10 Finland

Glomerular disease states in microscopic polyangiitis

29.1

47.3

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.7

47.2

1054

6347

J99.1

ICD-10 Finland

Respiratory disorders in other diffuse connective tissue disorders

27.1

47.2

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

2.8

47.1

320

1161

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

2.1

47.1

572

2789

5551A

ICD-9 Finland

Regional enteritis, Large intestine

24.0

47.0

H15.1

ICD-10 Finland

Episcleritis

2.7

46.9

324

1189

56300

ICD-8 Finland

Chronic enteritis and ulcerative colitis, Regional enteritis

12.5

46.9

M71.2

ICD-10 Finland

Synovial cyst of popliteal space [Baker]

2.0

46.8

615

3095

WXQ12

NOMESCO Finland

Psoralen - Ultraviolet A therapy with local sensitivisation

5.7

46.8

138

243

6BA02

NOMESCO Finland

6.5

46.8

125

194

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

2.2

46.7

515

2411

L04AC18

ATC

risankizumab; parenteral

51.0

46.7

RT350

NOMESCO Finland

11.0

46.6

L57.0

ICD-10 Finland

Actinic keratosis

1.5

46.6

1479

9760

A98

ICPC

Health maint/preventive medicine

1.5

46.3

24073

234180

ZX100

NOMESCO Finland

Oral

2.8

46.2

304

1084

9283

FHL

Subtalar joint ossification surgery (or triple)

14.7

46.2

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

2.4

46.1

395

1637

5AB14

NOMESCO Finland

9.5

46.1

101

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

46.1

3002

22800

M08.2

ICD-10 Finland

Juvenile arthritis with systemic onset

22.4

46.0

4AB0X

NOMESCO Finland

235.2

46.0

XX6XT

NOMESCO Finland

Other intravascular therapy with radiological guidance

6.6

45.8

121

185

ND1CG

NOMESCO Finland

Wrist and hand extensive MRI examination with high intensity magnet

3.4

45.7

231

686

ZX114

NOMESCO Finland

Intramuscular

2.6

45.7

337

1287

NDG77

NOMESCO Finland

Other excision, reconstruction or fusion of joint of first finger

6.9

45.6

116

168

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.7

45.5

1046

6349

EG1AA

NOMESCO Finland

Mandibular joint X-ray examination

5.2

45.5

146

284

NHL50

NOMESCO Finland

Tenolysis or tenosynovectomy of foot

5.2

45.5

144

276

M60.9

ICD-10 Finland

Myositis, unspecified

4.9

45.4

152

310

NHG20

NOMESCO Finland

Fusion of talocrural joint

4.3

45.3

172

399

WZA00

NOMESCO Finland

Short statement of of health and health related matters

1.6

45.2

1171

7347

M34.0

ICD-10 Finland

Progressive systemic sclerosis

15.3

45.1

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.8

44.9

812

4585

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.3

44.9

3348

25967

NH1AD

NOMESCO Finland

Ankle and foot CT

2.3

44.9

431

1893

L01XX50

ATC

[U] ixazomib; oral

+∞

44.8

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.2

44.7

12039

108515

QDH05

NOMESCO Finland

Correction of deformity of toe nail

6.4

44.6

120

188

NC1AE

NOMESCO Finland

Elbow ultrasound examination

10.8

44.6

N18.8

ICD-10 Finland

Other chronic renal failure

2.2

44.4

456

2067

RJ420

NOMESCO Finland

5.5

44.2

134

244

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

1.7

44.2

938

5567

L03AA02

ATC

filgrastim; parenteral

2.1

43.9

517

2490

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.5

43.9

1606

10939

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

3.6

43.9

208

587

NHK40

NOMESCO Finland

Osteotomy or rotation osteotomy of II-V metatarsal or tarsal bone

2.4

43.8

379

1578

XCK00

NOMESCO Finland

Perimetry

1.6

43.7

1165

7366

Z49.1

ICD-10 Finland

Extracorporeal dialysis

2.9

43.7

281

986

M48.0

ICD-10 Finland

Spinal stenosis

1.4

43.7

1983

14124

TDM10

NOMESCO Finland

Puncture of maxillary antrum

1.8

43.7

761

4244

Z93.2

ICD-10 Finland

Ileostomy status

6.0

43.6

123

205

X59

ICD-10 Finland

Exposure to unspecified factor

1.3

43.6

3585

28193

UJF02

NOMESCO Finland

Peroral enteroscopy

4.4

43.6

163

373

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.2

43.6

480

2247

NH1EA

NOMESCO Finland

Ankle X-ray examination with load or wrench

5.1

43.4

140

274

N08.5*M32.1

ICD-10 Finland

Glomerular disorders in systemic lupus erythematosus

17.9

43.4

K76.9

ICD-10 Finland

Liver disease, unspecified

2.7

43.1

302

1119

RF210

NOMESCO Finland

2.0

43.1

556

2780

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

2.2

43.1

438

1976

D09AB01

ATC

zinc bandage without supplements; topical

2.4

43.1

379

1595

H40.5

ICD-10 Finland

Glaucoma secondary to other eye disorders

3.4

42.9

214

630

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

3.7

42.9

195

533

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.0

42.5

578

2951

B81

ICPC

Anaemia vit B12/folate deficiency

1.9

42.5

620

3252

QXA20

NOMESCO Finland

Skin abrasion, unspecified location

5.9

42.4

121

205

Z85.6

ICD-10 Finland

Personal history of leukaemia

27.7

42.4

M65.9

ICD-10 Finland

Synovitis and tenosynovitis, unspecified

2.1

42.2

496

2387

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.7

42.2

308

1170

B01AB04

ATC

dalteparin; parenteral

1.7

42.1

862

5058

6112

FHL

Installation of a peritoneal dialysis or lavage catheter in an operating room

36.0

42.1

D07CC01

ATC

betamethasone and antibiotics; topical

1.4

42.1

2444

18197

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

4.2

42.1

164

391

N02BA01

ATC

acetylsalicylic acid; systemic, rectal

15.7

42.0

A02BB01

ATC

misoprostol; oral

4.4

41.9

157

360

L93.0

ICD-10 Finland

Discoid lupus erythematosus

4.5

41.8

151

334

RJ190

NOMESCO Finland

7.5

41.6

100

134

M03BX02

ATC

tizanidine; oral

1.2

41.6

13630

124761

K03.66

ICD-10 Finland

Tooth plaque

1.6

41.5

1217

7879

NHF80

NOMESCO Finland

Operation for debridement of toe joint, open

12.5

41.5

M01AB08

ATC

etodolac; oral

1.5

41.4

1401

9377

A01AB09

ATC

miconazole; local oral

1.5

41.4

1592

10958

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.2

41.3

8322

72728

RJ412

NOMESCO Finland

9.3

41.3

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

41.3

4801

39499

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.5

41.1

1315

8688

D07BC01

ATC

betamethasone and antiseptics; topical

1.4

40.9

2214

16276

N06AA09

ATC

amitriptyline; systemic

1.4

40.9

1828

12975

C08CA02

ATC

felodipine; oral

1.5

40.7

1441

9746

R11

ICD-10 Finland

Nausea and vomiting

1.5

40.7

1438

9723

M02AA10

ATC

ketoprofen; topical

1.3

40.6

2939

22657

WW400

NOMESCO Finland

Plasmaferesis

8.7

40.6

103

9260

FHL

Alloarthroplasty, endoprosthesis or implant

26.7

40.6

SBB00

NOMESCO Finland

Fotograf of mouth and teeth

1.8

40.6

754

4295

H15.0

ICD-10 Finland

Scleritis

5.7

40.6

120

213

L01XE31

ATC

[U] nintedanib; oral

11.9

40.5

RF212

NOMESCO Finland

5.7

40.4

118

206

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

0.6

40.3

616

10223

NCM20

NOMESCO Finland

Excision of synovial ganglion of elbow or forearm

5.8

40.1

117

204

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.2

40.1

5410

45273

Z94.2

ICD-10 Finland

Lung transplant status

9.6

40.1

WX302

NOMESCO Finland

Thoracal epidural anesthesy

1.7

40.1

933

5688

WW409

NOMESCO Finland

Other aferesis

7.1

39.9

139

WW402

NOMESCO Finland

Leucoferesis

10.1

39.9

B05DB

ATC

Hypertonic solutions

4.1

39.9

158

383

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.8

39.7

756

4342

56310

ICD-8 Finland

Chronic enteritis and ulcerative colitis, Ulcerative colitis

4.9

39.6

132

269

J99.0*M05.1

ICD-10 Finland

Rheumatoid lung disease

38.5

39.6

E85.3

ICD-10 Finland

Secondary systemic amyloidosis

24.4

39.6

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

2.8

39.5

268

975

C08CA01

ATC

amlodipine; oral

1.2

39.5

6175

52502

SHA03

NOMESCO Finland

Correction of physiology of bite - demanding therapy visit

1.9

39.5

620

3339

N05.8

ICD-10 Finland

Unspecified nephritic syndrome, other

22.8

39.5

N04.80

ICD-10 Finland

Congenital nephrotic syndrome of the Finnish type

52.3

39.4

115

Kela drug reimbursment

Breast cancer

0.6

39.4

668

10823

M54.5

ICD-10 Finland

Low back pain

1.2

39.3

6583

56378

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

1.4

39.2

1870

13436

TEG10

NOMESCO Finland

Injection of diagnostic or therapeutic substance into mandibular joint

10.3

39.2

M35.8

ICD-10 Finland

Other specified systemic involvement of connective tissue

9.3

39.1

N02AC04

ATC

dextropropoxyphene; oral

1.9

39.1

582

3077

L50

ICPC

Musculoskeletal, Medication/prescr/renewal

4.8

38.9

134

283

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.4

38.8

350

1491

M32

ICD-10 Finland

Systemic lupus erythematosus

11.8

38.8

K73.9

ICD-10 Finland

Chronic hepatitis, unspecified

5.8

38.8

113

197

JF1DM

NOMESCO Finland

Very extensive MRI of small bowel (more than 1.5 T)

25.7

38.8

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.0

38.7

535

2751

L95.9

ICD-10 Finland

Vasculitis limited to skin, unspecified

4.6

38.6

137

298

J45.9

ICD-10 Finland

Asthma, unspecified

1.3

38.5

3282

25899

L16

ICPC

Ankle symptom/complaint

1.4

38.4

1881

13577

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

6.2

38.4

105

169

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

2.7

38.4

268

991

1CX01

NOMESCO Finland

9.7

38.4

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.4

38.2

1812

13004

M65.8

ICD-10 Finland

Other synovitis and tenosynovitis

2.1

38.1

431

2043

EG1DG

NOMESCO Finland

Very extensive MRI examination of mandipular joint with high intensity magnet

12.9

38.1

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.4

38.0

1865

13465

RJ210

NOMESCO Finland

6.8

37.9

143

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.3

37.8

4378

35939

WX202

NOMESCO Finland

Supraclavicular plexus blockade

2.5

37.8

299

1189

N05CF01

ATC

zopiclone; oral

1.2

37.7

5973

50805

212

Kela drug reimbursment

Gout

2.5

37.7

303

1217

J04BA02

ATC

dapsone; oral

4.3

37.7

143

333

ZXC50

NOMESCO Finland

Cryotherapy

2.0

37.7

469

2312

JFH20

NOMESCO Finland

Proctocolectomy and ileostomy

13.9

37.6

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.7

37.6

813

4850

Z94.1

ICD-10 Finland

Heart transplant status

6.7

37.5

145

M05.2

ICD-10 Finland

Rheumatoid vasculitis

24.1

37.4

EB1WA

NOMESCO Finland

3.7

37.4

168

456

TFJ02

NOMESCO Finland

Muscle biopsy of heart

7.7

37.3

115

L03AB08

ATC

interferon beta-1b; parenteral

6.0

37.2

105

176

I77.6

ICD-10 Finland

Arteritis, unspecified

7.4

37.2

122

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.4

37.1

1791

12893

GDA11

NOMESCO Finland

Thoracoscopic biopsy of lung

5.7

36.9

108

190

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.7

36.8

777

4605

K61.0

ICD-10 Finland

Anal abscess

2.4

36.8

321

1344

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.5

36.5

1199

7968

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.7

36.4

805

4837

TEG00

NOMESCO Finland

Punction of mandibular joint

9.5

36.2

TJJ00

NOMESCO Finland

Percutaneous needle biopsy of liver

5.9

36.2

103

175

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

3.7

36.1

161

434

SPAT1254

SPAT

Administration of medicine

1.3

36.1

2573

19771

M09.0*L40.5

ICD-10 Finland

Juvenile arthritis in psoriasis

60.0

36.1

NF1AT

NOMESCO Finland

Puncture of hip joint with ultrasound guidance

4.9

36.0

121

249

H40.4

ICD-10 Finland

Glaucoma secondary to eye inflammation

9.6

36.0

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.4

35.8

2018

14927

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

2.1

35.8

432

2103

SDA02

NOMESCO Finland

Parodonthologic therapy

1.2

35.8

6672

57652

M02.3

ICD-10 Finland

Reiter disease

10.0

35.8

J47

ICD-10 Finland

Bronchiectasis

2.4

35.7

314

1320

RT160

NOMESCO Finland

9.3

35.7

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.4

35.7

2316

17533

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

1.9

35.7

525

2763

JF1CM

NOMESCO Finland

Small bowel extensive MRI with with high intensity magnet

18.4

35.6

RT231

NOMESCO Finland

18.4

35.6

K06.18

ICD-10 Finland

Another gingival hyperplasia

5.7

35.5

104

183

L04AA05

ATC

[U] tacrolimus; systemic

11.4

35.5

C07AB07

ATC

bisoprolol; oral

1.2

35.5

8513

75333

QDE99

NOMESCO Finland

Other excision or repair of lesion of skin of lower limb

3.1

35.4

203

661

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

35.4

483

2473

BE00A

NOMESCO Finland

52.5

35.3

107

Kela drug reimbursment

Pernicious anaemia

2.3

35.1

320

1372

V03AG01

ATC

sodium cellulose phosphate; systemic

10.5

35.1

NHQ40

NOMESCO Finland

Amputation of toe

2.6

35.1

267

1040

I41.8

ICD-10 Finland

Myocarditis in other diseases classified elsewhere

10.2

35.0

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.2

35.0

5345

45227

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.9

35.0

567

3089

JN4BD

NOMESCO Finland

Extensive body CT

1.4

34.8

1849

13539

TNH33

NOMESCO Finland

Custom moulded brace, ankle or foot

2.3

34.8

318

1367

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

1.8

34.7

626

3532

TCA20

NOMESCO Finland

Peribulbar therapeutic injection into orbit

7.9

34.7

101

SPAT1216

SPAT

Assessment of functional ability

1.3

34.7

2487

19117

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.3

34.7

2440

18707

SPAT1262

SPAT

Handing over of treatment supplies

1.3

34.6

3193

25440

NK6PA

NOMESCO Finland

Measurement of bone density from one location with X-ray

5.8

34.5

170

SPAT1260

SPAT

Consultation of another employee

1.3

34.5

3319

26589

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.0

34.5

449

2255

RK250

NOMESCO Finland

4.3

34.5

132

311

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.3

34.4

2358

17999

L30.3

ICD-10 Finland

Infective dermatitis

1.8

34.4

604

3380

O99.1

ICD-10 Finland

Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium

3.9

34.4

147

383

NXL00

NOMESCO Finland

Biopsy of muscle

5.2

34.3

108

207

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.4

34.3

311

1331

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.3

34.1

3579

28993

R01AD09

ATC

mometasone; nasal

1.2

33.9

9462

84767

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

2.4

33.8

287

1187

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.5

33.7

1067

7032

B02

ICD-10 Finland

Zoster [herpes zoster]

1.8

33.7

622

3539

L15

ICPC

Knee symptom/complaint

1.3

33.7

3880

31784

K73.0

ICD-10 Finland

Chronic persistent hepatitis, not elsewhere classified

17.1

33.5

K00.40

ICD-10 Finland

Postnatal enamel hypoplasia

3.9

33.4

142

368

A01

ICPC

Pain general/multiple sites

1.5

33.4

1327

9188

WX892

NOMESCO Finland

Monitored bed care

1.5

33.2

1267

8701

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

5.3

33.1

103

195

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.5

33.1

1252

8585

N18.0

ICD-10 Finland

End-stage renal disease

2.8

33.0

218

780

I73.0

ICD-10 Finland

Raynaud syndrome

2.3

33.0

309

1344

XQ841

NOMESCO Finland

Examination of dermatosis with microscope

7.9

33.0

71240

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Spondylitis ankylopoietica

6.1

33.0

149

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.2

33.0

4713

39562

Z94.9

ICD-10 Finland

Transplanted organ and tissue status, unspecified

10.3

32.9

UKC02

NOMESCO Finland

Cystoscopy

1.3

32.9

2482

19217

L26

ICD-10 Finland

Exfoliative dermatitis

7.0

32.9

117

WX290

NOMESCO Finland

Other blockade of nerve

1.2

32.8

9420

84504

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

2.8

32.8

222

808

M073L

ICD-10 Finland

74.2

32.8

EBA10

NOMESCO Finland

Surgical removal of tooth

1.3

32.8

2294

17561

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

2.3

32.7

304

1317

9294

FHL

Endoprosthesis replacement of the entire hip joint (eg Charnley)

3.8

32.7

142

375

JGB50

NOMESCO Finland

Mucosal proctectomy and ileoanal anastomosis

15.0

32.5

D06BX01

ATC

metronidazole; topical

1.4

32.4

1913

14252

M02.1

ICD-10 Finland

Postdysenteric arthropathy

5.7

32.4

164

GDG10

NOMESCO Finland

Bilateral transplantation of lung

10.3

32.4

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.2

32.4

5359

45672

A03

ICPC

Fever

1.3

32.3

3088

24698

RS224

NOMESCO Finland

4.0

32.3

132

331

H221, M084

ICD-10 Finland

+∞

32.3

H57.1

ICD-10 Finland

Ocular pain

1.8

32.3

587

3322

R05

ICPC

Cough

1.2

32.2

4252

35359

H02BX01

ATC

methylprednisolone, combinations; systemic

1.6

32.2

847

5333

JFB00

NOMESCO Finland

Partial resection of small intestine

2.4

32.2

279

1167

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

1.9

32.2

498

2671

M01AE52

ATC

naproxen and esomeprazole; oral

1.8

32.2

610

3499

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.5

32.1

990

6483

D05AC01

ATC

dithranol; topical

12.4

32.1

JFB33

NOMESCO Finland

Other resection comprising small intestine and colon

7.9

32.1

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

32.0

10288

93110

SPAT1310

SPAT

Counselling related to known health issue

1.2

32.0

6347

55055

M30.0

ICD-10 Finland

Polyarteritis nodosa

11.8

31.9

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.7

31.9

686

4089

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

2.3

31.9

310

1375

QCB10

NOMESCO Finland

Major dressing of wound of skin of upper limb

2.0

31.8

413

2074

FJA10

NOMESCO Finland

Transvenous biopsy of right ventricle

4.1

31.8

127

312

NDG20

NOMESCO Finland

Fusion of wrist, partial

3.7

31.8

140

375

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.3

31.8

2314

17821

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.1

31.7

385

1882

L52

ICD-10 Finland

Erythema nodosum

3.3

31.6

164

501

7143X

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Juvenile chronic polyarthritis[POLYARTHRITIS JUVENILIS NUD]

30.0

31.5

NHF15

NOMESCO Finland

Synovectomy of ankle, arthroscopic

6.6

31.4

125

5559X

ICD-9 Finland

Regional enteritis, Unspecified site

26.9

31.4

M87.1

ICD-10 Finland

Osteonecrosis due to drugs

5.4

31.4

179

JJC00

NOMESCO Finland

Allogenic transplantation of liver

6.2

31.4

140

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.3

31.3

2602

20414

N06AX21

ATC

duloxetine; oral

1.4

31.2

1961

14756

XF600

NOMESCO Finland

Bloodpressure measurement

1.5

31.2

1082

7283

V03AE01

ATC

polystyrene sulfonate; oral

2.7

31.1

212

776

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

4.2

31.1

119

281

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

1.6

31.1

917

5946

L02BG04

ATC

letrozole; oral

0.6

31.0

495

8140

0108

NOMESCO Finland

28.0

31.0

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.5

31.0

1018

6769

R01AD12

ATC

fluticasone furoate; nasal

1.2

30.9

6022

52106

H53.2

ICD-10 Finland

Diplopia

1.8

30.9

513

2820

4AA09

NOMESCO Finland

25.3

30.9

JFH10

NOMESCO Finland

Total colectomy and ileostomy

6.1

30.7

140

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

2.2

30.7

328

1519

M09.1*K50.9

ICD-10 Finland

Juvenile arthritis in Crohn's disease [regional enteritis]

85.1

30.7

69600

ICD-8 Finland

Psoriasis and similar disorders, Psoriatic arthropathy

13.6

30.6

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

1.6

30.6

827

5246

NFC40

NOMESCO Finland

Repair of hip prosthesis by bone transplant to acetabulum

4.5

30.6

111

249

L04AA31

ATC

teriflunomide; oral

5.1

30.5

189

A07DA03

ATC

loperamide; oral

1.7

30.5

591

3416

NJ3CG

NOMESCO Finland

Extensive MRI examination of extremities with median high magnet

4.5

30.5

111

250

NHL68

NOMESCO Finland

Tenodesis, shortening or lengthening of tendon of foot

2.4

30.3

252

1034

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

30.3

8945

80269

RT172

NOMESCO Finland

8.4

30.2

N05AH02

ATC

clozapine; systemic

0.3

30.2

2075

D11AH01

ATC

tacrolimus; topical

2.8

30.2

201

725

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.2

30.1

7478

66111

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

1.5

30.0

1217

8464

M31.8

ICD-10 Finland

Other specified necrotizing vasculopathies

12.9

30.0

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

7.7

29.9

M01AH03

ATC

valdecoxib; oral

1.5

29.9

1125

7703

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

2.6

29.8

225

876

4AC05

NOMESCO Finland

82.6

29.7

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

1.5

29.7

1061

7185

M35.2

ICD-10 Finland

Behçet disease

16.0

29.7

ND2CG

NOMESCO Finland

Extensive MRI of hand

5.5

29.6

163

XQ802

NOMESCO Finland

Epicutan test

1.6

29.6

741

4608

J20

ICD-10 Finland

Acute bronchitis

1.4

29.5

1669

12339

SPAT1204

SPAT

Arthrocentesis

3.1

29.5

167

543

M31.0

ICD-10 Finland

Hypersensitivity angiitis

18.8

29.5

SPAT1251

SPAT

Organisation of medication

1.7

29.2

578

3363

B01AA03

ATC

warfarin; systemic

1.3

29.1

2813

22506

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.3

29.1

2336

18227

K02.0

ICD-10 Finland

Caries limited to enamel

1.3

29.1

2647

21019

M34.8

ICD-10 Finland

Other forms of systemic sclerosis

18.0

29.1

NG4AA

NOMESCO Finland

Lower leg X-ray examination

1.8

29.0

506

2831

R01AD08

ATC

fluticasone; nasal

1.2

29.0

5654

48879

-50

ICPC

Medication/prescr/renewal

1.6

28.9

711

4404

NEA10

NOMESCO Finland

Exploration of soft tissue of pelvis, percutaneous

4.3

28.8

109

255

L01XG03

ATC

ixazomib; oral

292.1

28.8

B01AB10

ATC

tinzaparin; parenteral

1.5

28.6

1155

8022

D06BB10

ATC

imiquimod; topical

1.6

28.6

775

4918

5602

FHL

Internal fistula (eg Cimino)

33.7

28.6

NHK99

NOMESCO Finland

Other operation on bone of ankle or foot

2.2

28.6

305

1413

1AA01

NOMESCO Finland

12.1

28.6

M81.8

ICD-10 Finland

Other osteoporosis

3.2

28.5

153

480

L95.8

ICD-10 Finland

Other vasculitis limited to skin

5.5

28.4

155

6119

FHL

Other measure in this category

48.6

28.3

Z99.2

ICD-10 Finland

Dependence on renal dialysis

8.3

28.3

M09.2*K51.9

ICD-10 Finland

Juvenile arthritis in ulcerative colitis

26.0

28.3

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.6

28.3

809

5204

RT274

NOMESCO Finland

6.3

28.3

121

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

1.2

28.2

5745

49836

L29

ICPC

Musculoskeletal sympt/complt other

1.4

28.2

1278

9082

SBB10

NOMESCO Finland

Teeth copy

1.4

28.2

1199

8415

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.4

28.2

1366

9831

PBM10

NOMESCO Finland

Closure of arteriovenous fistula of radial artery

7.3

28.2

M30.1

ICD-10 Finland

Polyarteritis with lung involvement [Churg-Strauss]

11.3

28.2

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.2

28.1

3613

29909

TPH07

NOMESCO Finland

Cathetrisation of artery

1.4

28.1

1678

12517

4AA17

NOMESCO Finland

+∞

28.1

JHD30

NOMESCO Finland

Incomplete incision of fistula-in-ano

5.5

28.1

153

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

1.4

28.0

1229

8679

M70.6

ICD-10 Finland

Trochanteric bursitis

1.3

27.9

2047

15761

SFA00

NOMESCO Finland

Small filling

1.3

27.9

2388

18793

TCF00

NOMESCO Finland

Subconjunctival therapeutic injection

6.2

27.9

123

JFB21

NOMESCO Finland

Laparoscopic ileocaecal resection

7.4

27.9

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

1.8

27.9

518

2953

317

Kela drug reimbursment

Topical pimecrolimus and tacrolimus

2.2

27.9

284

1288

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

0.3

27.8

2113

M94.1

ICD-10 Finland

Relapsing polychondritis

22.2

27.7

R5140

NOMESCO Finland

Monitoring the use of the aid

1.4

27.7

1759

13249

1008

NOMESCO Finland

7.8

27.7

KMAK

NOMESCO Finland

1.2

27.7

11113

101915

RF421

NOMESCO Finland

3.4

27.7

139

415

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.1

27.7

325

1570

K51.4

ICD-10 Finland

Inflammatory polyps

14.8

27.7

E000004

ATC

2.0

27.6

380

1953

H16.0

ICD-10 Finland

Corneal ulcer

1.6

27.6

803

5186

B34.9

ICD-10 Finland

Viral infection, unspecified

1.8

27.6

506

2877

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.0

27.5

365

1853

M49.5*C90.0

ICD-10 Finland

Vertebral fracture due to multiple myeloma

28.5

27.5

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

1.6

27.4

681

4227

S01ED51

ATC

timolol, combinations; ophthalmic

1.5

27.3

1043

7160

M06.2

ICD-10 Finland

Rheumatoid bursitis

21.1

27.3

K92.1

ICD-10 Finland

Melaena

1.6

27.2

736

4670

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

2.8

27.2

181

655

N04AA02

ATC

biperiden; systemic

0.3

27.2

1992

K05.30

ICD-10 Finland

Periodontitis complex

1.3

27.2

2125

16518

R74.0

ICD-10 Finland

Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]

2.1

27.1

305

1447

164

Kela drug reimbursment

Fingolimod

4.8

27.1

189

S01FA02

ATC

scopolamine; ophthalmic

2.8

27.1

183

667

J01CF05

ATC

flucloxacillin; systemic

1.7

27.1

635

3881

P72

ICPC

Schizophrenia

0.3

27.1

1865

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

2.6

27.1

200

770

TNX92

NOMESCO Finland

Supporting bandage or orthosis of lower limb

2.1

27.0

320

1549

M50.8

ICD-10 Finland

Other cervical disc disorders

3.6

27.0

125

350

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

1.7

27.0

523

3024

L28.1

ICD-10 Finland

Prurigo nodularis

3.2

27.0

144

450

NAG42

NOMESCO Finland

Posterior fusion of cervical spine with or without fixation

6.0

27.0

125

NGF10

NOMESCO Finland

Total synovectomy of knee, open

6.7

27.0

103

K59.1

ICD-10 Finland

Functional diarrhoea

1.5

26.9

839

5509

S29

ICPC

Skin symptom/complaint other

1.3

26.7

2953

24010

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.4

26.7

1254

8970

L60.0

ICD-10 Finland

Ingrowing nail

1.6

26.6

731

4655

1XX02

NOMESCO Finland

96.7

26.6

ZX131

NOMESCO Finland

Intrathecal

15.9

26.6

R51.80

ICD-10 Finland

Headache

1.3

26.6

2732

22022

ZX121

NOMESCO Finland

Central venous catheter

3.9

26.5

111

286

C90.2

ICD-10 Finland

Extramedullary plasmacytoma

11.1

26.4

K06.19

ICD-10 Finland

Gingival hyperplasia UNS

4.2

26.4

101

240

JL5AG

NOMESCO Finland

Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet

2.8

26.4

175

633

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

1.9

26.2

382

2010

F20.9

ICD-10 Finland

Schizophrenia, unspecified

0.4

26.2

2266

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.2

26.2

5098

43995

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.2

26.1

10520

96341

DHA10

NOMESCO Finland

Biopsy of cavity of nose

2.9

26.1

164

574

K03.64

ICD-10 Finland

Dental calculus supragingival

1.2

26.0

5587

48636

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

2.0

26.0

324

1605

TEA00

NOMESCO Finland

Biopsy of lip

2.7

26.0

181

674

L40.1

ICD-10 Finland

Generalized pustular psoriasis

11.1

26.0

H20

ICD-10 Finland

Iridocyclitis

3.9

26.0

108

277

WX882

NOMESCO Finland

High dependency care

1.8

25.9

467

2638

NH1CM

NOMESCO Finland

Ankle and foot extensive MRI examination with 3 Tesla magnet

5.9

25.9

124

N03.9

ICD-10 Finland

Chronic nephritic syndrome, unspecified

4.2

25.8

100

240

F29

ICD-10 Finland

Unspecified nonorganic psychosis

0.5

25.8

230

4401

NG1CG

NOMESCO Finland

Knee and lower leg extensive MRI examination with high intensity magnet

1.9

25.8

405

2188

M01AB05

ATC

diclofenac; systemic, rectal

1.2

25.8

14355

134522

SCA02

NOMESCO Finland

Analysis and advice of nutrition with regard to dentistry

1.3

25.8

1883

14490

JHD33

NOMESCO Finland

Completing incision of fistula-in-ano

5.1

25.8

161

RF430

NOMESCO Finland

4.9

25.7

174

K74.3

ICD-10 Finland

Primary biliary cirrhosis

3.3

25.7

132

402

L04AA14

ATC

[U] anakinra; parenteral

135.0

25.6

D86.0

ICD-10 Finland

Sarcoidosis of lung

2.3

25.6

235

1015

M05BX03

ATC

strontium ranelate; oral

3.4

25.6

127

377

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.4

25.6

1398

10275

7102B

ICD-9 Finland

Diffuse diseases of connective tissue, Sicca syndrome[SYNDROMA SICCUM SECUNDARIUM]

14.3

25.5

B01AF01

ATC

rivaroxaban; oral

1.3

25.5

1840

14132

L45

ICPC

Musculoskeletal, Observ/health educat/advice/diet

11.2

25.5

D01AE16

ATC

amorolfine; topical

1.3

25.4

1945

15066

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

1.9

25.4

371

1954

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.4

25.4

1099

7742

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

4.9

25.3

169

7230B

ICD-9 Finland

Other disorders of cervical region, Spinal stenosis of cervical region[SUBLUXATIO ATLANTO-AXIALIS]

50.0

25.2

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

1.5

25.2

918

6243

7165A

ICD-9 Finland

Other and unspecified arthropathies, Unspecified polyarthropathy or polyarthritis

10.4

25.1

NBB20

NOMESCO Finland

Primary total prosthetic replacement of humero-scapular joint

2.6

25.1

192

755

JN4AD

NOMESCO Finland

Body CT examination

1.4

25.1

1193

8552

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.3

25.1

2387

19047

H221, M083

ICD-10 Finland

+∞

25.0

D01AC02

ATC

miconazole; topical

1.4

25.0

1254

9078

J99.0

ICD-10 Finland

Rheumatoid lung disease

58.0

25.0

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

1.6

24.9

642

4024

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

1.8

24.9

426

2367

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.4

24.9

1432

10613

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

2.2

24.8

247

1111

M07.2

ICD-10 Finland

Psoriatic spondylitis

26.2

24.8

D05AX

ATC

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(1175426) CD3 cells/100 lymphocytes in Blood

760

1665

4.66

318.74

2.3

2.1

74.1

72.2

2.50

726

1608

(3008757) Leukocyte morphology finding [Identifier] in Blood

870

2133

4.17

315.76

3.8

3.5

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1498

5237

2.96

313.70

4.8

1.8

g/l

0.0

0.09

1380

4766

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1611

5863

2.85

313.43

4.7

1.7

g/l

37.0

38.1

10.70

1435

5039

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

775

1752

4.51

312.53

1.4

1.2

titre

221.7

124.7

0.83

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

746

1639

4.64

311.74

2.3

2.1

13.2

13.8

0.42

345

815

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

775

1758

4.50

311.18

1.4

1.2

titre

226.1

175.1

0.96

236

228

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

664

1327

5.09

310.67

1.9

1.7

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1415

4819

3.03

310.37

1.7

1.4

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1479

5166

2.96

310.15

4.9

1.8

g/l

0.0

0.00

1378

4749

(3017354) Segmented neutrophils/100 leukocytes in Blood

813

1929

4.30

308.10

3.1

3.3

59.0

57.9

0.60

534

1247

(3004616) Nuclear Ab [Presence] in Serum

971

2623

3.79

307.91

1.4

1.3

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

1043

147

73.51

307.65

1.8

1.6

au/ml

123.1

205.6

0.89

134

(3018418) pH of Serum or Plasma

11339

66543

2.15

307.65

5.9

3.9

7.4

0.08

2361

12528

(3011412) CD3 cells [#/volume] in Blood

970

2043

4.87

307.65

2.3

2.5

e9/l

1.1

1.2

1.90

568

1257

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

2501

1470

18.50

307.65

1.1

iu/ml

1.4

2.4

1.51

(3009445) Proteinase 3 Ab [Units/volume] in Serum

3204

9023

3.86

307.65

2.7

1.3

u/ml

17.6

8.9

3.65

273

128

(3002030) Lymphocytes/100 leukocytes in Blood

24575

111942

8.34

307.65

17.2

4.7

27.8

28.7

37.54

24166

103960

(3010144) Erythrocytes [#/volume] in Synovial fluid

1168

1551

7.80

307.65

1.7

1.2

e6/l

33469.4

149281.2

7.03

832

1045

(3048689) Calprotectin [Mass/mass] in Stool

8067

29400

3.40

307.65

6.2

1.8

ug/g

199.6

118.7

61.48

7312

22513

(3004789) Transferrin [Mass/volume] in Serum or Plasma

6390

32138

2.26

307.65

2.9

2.4

g/l

2.3

2.4

8.29

6041

29711

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1845

4459

4.35

307.65

1.4

1.2

u/ml

4.4

4.7

0.07

187

303

(3002179) Metamyelocytes/100 leukocytes in Blood

7132

15386

5.80

307.65

5.9

3.4

0.4

0.7

14.79

1534

3376

(3017181) Myelocytes/100 leukocytes in Blood

7574

17025

5.65

307.65

6.5

3.5

0.7

1.0

17.79

1999

4726

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

2148

5579

4.07

307.65

1.4

1.2

u/ml

15.0

6.3

5.04

493

779

(40759836) Histone Ab [Presence] in Serum by Immunoblot

865

1561

5.68

307.65

1.2

1.1

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2112

7515

2.95

307.65

5.0

1.7

g/l

7.5

7.3

2.09

1606

5645

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

865

1565

5.66

307.65

1.2

1.1

—

(3018095) Leukocytes [#/volume] in Urine

13591

80871

2.27

307.65

5.1

3.5

e6/l

62.5

90.7

4.10

9837

56078

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

27115

181007

7.53

307.65

15.7

6.7

u/l

73.2

78.1

100.25

26798

169911

(3029937) Albumin [Presence] in Urine by Test strip

10723

61495

2.17

307.65

6.6

3.7

estimate

0.0

3.43

4983

20248

(3042936) Bacteria identified in Isolate by Culture

6005

31711

2.12

307.65

2.3

2.0

—

(3006504) Eosinophils/100 leukocytes in Blood

24459

107620

8.63

307.65

17.0

4.6

2.7

2.9

18.91

24066

99862

(3009261) Glucose [Presence] in Urine by Test strip

19014

116763

2.78

307.65

5.6

3.4

estimate

0.0

0.89

4936

20474

(3026493) Urate [Moles/volume] in Serum or Plasma

10751

59690

2.26

307.65

3.4

2.5

umol/l

1630.8

4242.5

21.40

9769

51869

(3023420) DNA double strand Ab [Units/volume] in Serum

1855

1795

10.96

307.65

1.8

1.4

iu/ml

37.5

26.7

1.50

115

(3034860) Kappa light chains.free [Mass/volume] in Serum

1868

5960

3.28

307.65

9.1

2.2

mg/l

58.6

59.5

0.03

1488

4833

(3013707) Erythrocyte sedimentation rate by Westergren method

26741

176294

6.81

307.65

11.2

3.3

mm/h

13.3

11.3

97.46

26151

163046

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

377

55.32

307.65

1.8

1.5

mg/l

1.7

1.8

0.25

319

(3037522) Nuclear Ab [Titer] in Serum

10992

30324

5.19

307.65

1.6

1.3

titre

624.3

519.1

5.76

2997

5553

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1936

5863

3.46

307.65

2.2

1.3

iu/ml

12.6

18.0

0.96

109

(3004588) Protein electrophoresis panel - Serum or Plasma

3685

13310

3.02

307.65

5.2

1.8

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

16284

98163

2.48

307.65

7.8

4.6

g/l

35.7

35.9

4.55

15576

90997

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

5833

34863

1.84

307.65

2.2

1.8

—

(3006315) Basophils [#/volume] in Blood

26726

114746

15.85

307.65

16.6

4.5

e9/l

0.0

4.56

25582

98318

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

6479

4178

19.61

307.65

1.7

1.6

iu/ml

2.8

8.8

0.72

1346

869

(3021879) Hepatitis B virus core Ab [Presence] in Serum

5803

17178

3.96

307.65

1.3

1.5

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

8192

27432

3.75

307.65

1.5

1.7

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

2133

5490

4.11

307.65

1.4

1.2

u/ml

7.2

5.5

0.39

338

502

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

868

1584

5.61

307.65

1.2

1.1

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2111

7493

2.96

307.65

5.0

1.7

g/l

3.8

0.31

1538

5372

(3000850) Epithelial cells [#/volume] in Urine

8732

46828

2.23

307.65

3.4

2.5

e6/l

4.7

6.0

15.17

7965

40586

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2110

7506

2.95

307.65

5.0

1.7

—

(42870588) Differential panel, method unspecified - Blood

20750

76124

6.89

307.65

14.6

4.6

—

(3022145) Colonoscopy Study observation

6292

25496

2.87

307.65

1.9

1.3

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

4376

21636

2.20

307.65

2.3

2.2

nmol/l

332.7

377.4

43.32

4118

19899

(3037467) Urinalysis macro (dipstick) panel - Urine

23856

162761

3.49

307.65

7.7

3.9

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1832

5766

3.32

307.65

8.9

2.2

ratio

10.3

2.1

1.42

147

454

(3039162) Centromere protein B Ab [Units/volume] in Serum

1163

2713

4.42

307.65

1.4

1.2

u/ml

48.8

56.1

0.41

169

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1632

4641

3.66

307.65

1.4

1.2

u/ml

56.1

37.9

3.89

257

403

(3022096) Basophils/100 leukocytes in Blood

24226

104126

8.59

307.65

17.0

4.6

0.7

100.21

23826

96658

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

2489

9494

2.77

307.65

2.6

1.9

u/l

37.7

39.8

5.66

2285

8438

(3034891) Synovial lining cells/100 cells in Synovial fluid

762

743

10.50

307.65

1.7

1.3

4.8

3.5

0.99

212

147

(3021589) Normoblasts [#/volume] in Blood

19593

103970

3.66

307.65

19.8

8.2

e9/l

0.0

4.22

18018

84147

(3037756) Immunofixation for Serum or Plasma

1436

3808

3.91

307.65

3.0

1.4

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1420

4049

3.63

307.65

1.5

1.2

titre

159.5

112.3

0.52

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

1350

1489

9.45

307.65

1.9

1.3

37.4

28.1

11.08

888

891

(3002385) Erythrocyte distribution width [Ratio]

24350

205549

2.08

307.65

32.2

15.0

14.0

13.6

307.65

24209

201214

(3013650) Neutrophils [#/volume] in Blood by Automated count

27144

134011

14.63

307.65

20.1

7.8

e9/l

3.9

4.1

34.62

26070

115993

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

1280

189

70.75

307.65

2.1

1.8

mg/l

9.3

8.8

0.61

1024

150

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

10289

40162

3.40

307.65

1.4

1.3

iu/ml

73.1

26.1

37.04

4358

11739

(40758558) Short blood count panel - Blood

12156

58802

2.82

307.65

13.5

6.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

1280

3088

4.29

307.65

1.1

—

(40761535) Cells panel - Urine sediment

3722

17761

2.25

307.65

6.0

3.1

—

(3017732) Neutrophils [#/volume] in Blood

3840

15897

2.63

307.65

4.0

2.5

e9/l

4.0

4.1

0.44

2959

12525

(3001122) Ferritin [Mass/volume] in Serum or Plasma

14639

105851

1.76

307.65

3.6

2.8

ug/l

136.1

118.4

9.01

13864

98598

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

404

106

38.62

307.65

1.1

1.0

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

1276

3214

4.10

307.65

2.2

1.2

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

1335

189

73.93

307.65

2.7

3.5

au/ml

159.5

144.8

0.19

170

(46235355) HIV 1 and 2 tests - Meaningful Use set

8730

46246

2.26

307.65

1.7

1.9

—

(3021788) Differential panel - Synovial fluid

2391

3015

8.54

307.65

1.8

1.4

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

3264

4385

8.25

307.65

1.7

1.3

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

10449

55240

2.38

307.65

3.0

2.2

mg/l

3.1

2.9

13.03

9405

47138

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1437

4795

3.10

307.65

2.1

1.6

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

867

1582

5.62

307.65

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

867

1580

5.62

307.65

1.2

1.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

2246

6124

3.89

307.65

1.4

1.2

u/ml

34.8

37.8

0.21

169

341

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

1461

207

74.20

307.65

3.2

4.1

mg/l

8.0

8.7

0.68

1175

165

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

11192

79710

1.65

307.65

4.7

3.1

u/l

32.6

33.3

0.63

10629

75666

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

865

1567

5.66

307.65

1.2

1.1

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

28345

245010

5.57

307.65

28.0

12.3

mg/l

16.7

23.2

307.65

25895

189758

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

3095

6371

5.31

307.65

2.6

1.6

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1884

6340

3.11

307.65

5.1

1.9

g/l

1.2

0.7

4.08

1639

5463

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

6162

29634

2.37

307.65

3.0

2.5

22.4

23.1

2.98

5410

25343

(3027945) Reticulocytes/100 erythrocytes in Blood

4964

23196

2.37

307.65

3.5

2.5

1.8

1.46

4582

20530

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2007

7071

2.97

307.65

5.1

1.7

g/l

3.2

3.0

13.16

1552

5530

(3005719) IgG [Mass/volume] in Serum or Plasma

6327

16033

4.75

307.65

4.6

2.2

g/l

10.6

10.5

1.27

5979

14619

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

4383

15242

3.20

307.65

2.1

1.6

—

(3001604) Monocytes [#/volume] in Blood

26668

114236

15.59

307.65

16.5

4.4

e9/l

0.6

0.38

25518

97902

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

15545

102920

2.08

307.65

8.7

5.8

mmol/l

1.2

5.17

14640

93191

(3013115) Eosinophils [#/volume] in Blood

26828

119003

15.58

307.65

17.0

4.7

e9/l

0.2

60.36

25832

103697

(3022948) Iron [Moles/volume] in Serum or Plasma

6945

34877

2.30

307.65

2.9

2.5

umol/l

12.8

13.5

13.13

6606

32326

(3020564) Creatinine [Moles/volume] in Serum or Plasma

28475

260248

4.14

307.65

29.7

14.2

umol/l

75.5

75.1

1.34

28468

260132

(40760888) Immunoglobulin light chains.free panel - Serum

1537

4406

3.62

307.65

8.8

2.2

—

(3030467) Casts [#/volume] in Urine by Automated count

10467

62838

2.03

307.65

4.2

3.0

e6/l

0.3

0.4

8.25

8639

46261

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1635

5656

3.00

307.65

4.7

1.8

g/l

0.0

0.16

1510

5169

(3019198) Lymphocytes [#/volume] in Blood

26721

118266

15.05

307.65

16.7

4.5

e9/l

1.8

2.0

76.35

25747

103424

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2210

9195

2.52

307.65

1.8

1.7

g/l

1.5

0.59

1920

7876

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

4913

24426

2.21

307.65

4.6

4.3

u/l

242.5

242.3

0.02

4698

23124

(3028026) IgM [Mass/volume] in Serum or Plasma

4795

12506

4.39

307.65

2.4

1.7

g/l

1.1

1.3

14.08

4429

11420

(3026782) Osmolality of Urine

7133

43997

1.82

307.65

3.7

2.6

mosm/kgh2o

539.1

544.8

1.40

6393

37244

(3031040) Bacteria [#/volume] in Urine by Automated count

19239

156657

1.66

307.65

5.6

4.2

e6/l

1081.6

1480.3

0.34

200

2106

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

1810

1966

9.74

307.65

1.9

1.4

51.0

59.5

10.08

1230

1188

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

2520

7158

3.76

307.65

2.1

1.5

titre

391.3

203.7

2.93

183

238

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1940

7020

2.89

307.65

5.1

1.7

g/l

10.3

10.2

0.50

1644

5895

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

352

44.51

307.65

3.2

2.7

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

28517

261402

4.19

307.65

27.8

8.9

u/l

26.9

26.6

1.83

28352

252493

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

611

349

17.85

307.65

1.8

1.4

ug/l

8.9

9.2

0.59

611

349

(3021601) Nitrite [Presence] in Urine by Test strip

18911

115573

2.79

307.65

7.2

4.5

estimate

0.0

1.40

5050

21014

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

2471

7240

3.63

307.65

1.3

1.4

—

(3007164) IgA [Mass/volume] in Serum or Plasma

8550

47838

2.11

307.65

2.1

1.4

g/l

2.5

2.3

8.04

6057

28746

(3015171) Extractable nuclear Ab [Units/volume] in Serum

3564

8564

4.60

307.65

1.3

1.2

u/ml

1.2

0.8

1.19

321

741

(3024980) IgG subclass 4 [Mass/volume] in Serum

1344

3562

3.91

307.65

2.0

1.5

g/l

0.7

0.8

0.47

1023

2700

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

26149

228547

2.32

307.65

21.9

11.6

ml/min/173m2

86.6

83.7

87.16

23671

186763

(36304419) Bacteria [Presence] in Urine

10260

61579

2.02

307.65

4.1

2.9

—

(3009871) Measles virus Ab [Titer] in Serum

486

658

7.49

307.65

1.7

1.6

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1375

3358

4.25

307.65

4.6

2.7

u/ml

939.2

6712.5

1.02

109

175

(3007566) Smooth muscle Ab [Titer] in Serum

1951

6401

3.19

307.65

1.5

1.2

titre

192.0

101.5

2.11

214

563

(3010375) cycloSPORINE [Mass/volume] in Blood

668

817

8.34

307.65

26.4

30.0

ug/l

118.8

119.7

0.08

580

671

(3041096) Erythrocytes [Presence] in Urine by Automated

9756

63752

1.79

307.65

4.9

3.0

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

9974

53566

2.30

307.65

5.5

3.3

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1471

4950

3.07

307.65

2.1

1.6

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1700

4942

3.59

307.65

1.2

1.3

—

(3000475) Leukocytes [#/volume] in Synovial fluid

2956

4048

8.01

307.65

2.0

1.5

e6/l

9040.0

15346.4

9.05

2347

2818

(3044941) Cell count panel - Synovial fluid

1807

2667

7.15

307.65

1.6

1.3

—

(3020630) Protein [Mass/volume] in Serum or Plasma

4142

16580

2.74

307.65

5.3

2.1

g/l

66.3

66.7

1.72

3873

15104

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

16471

121933

1.80

307.65

7.6

6.0

umol/l

10.3

11.2

20.16

15833

115317

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

10360

37478

3.73

307.65

1.4

1.2

u/ml

45.2

4.5

139.44

4393

14499

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2204

4168

5.63

307.65

6.1

5.9

iu/ml

513.7

1494.3

1.52

307

623

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

18345

96199

3.42

307.65

3.2

2.2

nmol/l

77.4

1021.6

0.50

17596

86766

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

2681

6805

4.23

307.65

2.6

1.5

g/l

1.2

4.77

2580

6464

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

13488

90064

1.92

307.65

6.1

3.5

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1484

4501

3.42

307.65

1.5

1.3

u/ml

292.6

260.5

2.94

897

2932

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

9037

37201

3.06

307.65

1.5

1.7

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1745

6015

3.02

307.65

2.6

2.0

mg/l

10.7

10.8

0.24

1631

5609

(3025159) Blasts/100 leukocytes in Blood

7002

15263

5.71

307.65

6.7

3.5

0.1

0.3

1.12

1644

3682

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

16939

113590

2.16

307.65

9.9

6.4

mmol/l

1.2

2.59

14405

96048

(3024263) Appearance of Synovial fluid

573

911

6.39

307.65

2.8

1.4

—

(3004809) Band form neutrophils/100 leukocytes in Blood

1305

3171

4.26

307.65

3.1

3.3

1.0

1.6

6.13

1049

2451

(3014148) Varicella zoster virus Ab [Titer] in Serum

1245

2886

4.46

307.65

1.1

1.2

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1811

4440

4.28

307.65

1.3

1.2

u/ml

23.9

6.5

1.83

(3023520) Reticulocytes [#/volume] in Blood

3870

17024

2.47

307.65

2.8

2.7

e9/l

69.7

70.4

0.53

2939

12727

(3035350) Ketones [Presence] in Urine by Test strip

18891

115164

2.80

307.65

5.6

3.3

estimate

0.0

1.54

4865

20512

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1550

4790

3.36

307.65

1.5

1.2

—

(3008898) HLA-B27 [Presence]

2897

7859

3.98

307.65

1.1

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

2646

6581

4.32

307.65

2.6

1.5

g/l

0.2

21.23

2535

6229

(40760892) CBC W Ordered Manual Differential panel - Blood

13285

51109

3.92

307.65

10.5

3.4

—

(3002582) Erythrocytes [#/volume] in Urine

11024

68691

1.97

307.65

4.3

3.1

e6/l

45.1

84.6

4.28

9259

51651

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1870

5944

3.29

307.65

9.1

2.2

mg/l

56.2

40.0

1.70

1492

4818

(3023368) Bacteria identified in Blood by Culture

9604

58435

1.96

307.65

5.2

4.2

—

(3019069) Monocytes/100 leukocytes in Blood

24515

108290

8.67

307.65

17.5

4.8

9.0

8.4

179.66

24133

101096

(3021440) Promyelocytes/100 leukocytes in Blood

7256

16172

5.63

307.65

6.6

3.5

0.1

5.57

1883

4349

(3034770) Mitochondria Ab [Titer] in Serum

1916

6291

3.19

307.65

1.4

1.2

titre

930.6

919.2

0.02

196

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

6616

38584

1.92

307.65

3.3

2.7

e6/l

0.9

1.2

3.79

4410

21272

(3018010) Neutrophils/100 leukocytes in Blood

24475

110163

8.35

307.65

16.5

4.5

57.9

56.6

68.67

24079

102725

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

709

1512

4.78

307.23

3.0

1.5

mg/l

3.8

3.7

0.20

676

1442

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1404

4797

3.02

306.14

1.7

1.4

u/ml

23.6

20.6

0.25

100

(3000494) Fungus identified in Specimen by Culture

4748

27344

1.88

305.79

1.7

1.4

—

(3007853) Bacteria identified in Skin by Aerobe culture

4758

27437

1.88

305.13

2.0

1.7

—

(21494815) CD4 cells/100 lymphocytes in Specimen

794

1892

4.28

299.17

2.1

2.3

46.6

39.9

3.51

111

224

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

710

1552

4.66

298.50

2.3

2.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

1931

7893

2.55

298.32

1.5

1.3

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

1141

3523

3.33

294.94

2.1

1.6

—

(21494890) Protein electrophoresis panel - 24 hour Urine

787

1887

4.26

294.09

3.9

1.6

—

(3021960) Folate [Moles/volume] in Serum or Plasma

7629

50868

1.67

294.09

1.6

1.5

nmol/l

21.1

20.4

1.67

6733

43687

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

690

1495

4.70

293.24

2.5

2.6

e6/l

431.8

543.7

6.56

572

1241

(3010503) CD19 cells [#/volume] in Blood

607

1208

5.11

285.30

2.0

2.8

e9/l

0.1

0.3

1.53

589

1178

(40761536) Microorganisms panel - Urine sediment

3659

19745

1.97

285.03

5.3

3.7

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

668

1445

4.71

284.41

2.5

2.7

e9/l

0.2

5.92

575

1236

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

9657

68827

1.60

282.39

2.6

2.1

u/l

156.7

208.8

9.81

9205

64536

(3036071) Salmonella sp Ab [Titer] in Serum

429

617

7.04

281.67

1.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

1297

4451

3.00

280.25

1.7

1.4

u/ml

116.8

110.9

0.52

263

994

(3019309) Folate [Moles/volume] in Red Blood Cells

6190

39486

1.72

279.33

1.9

1.7

nmol/l

1175.6

1169.9

0.18

4881

29995

(3028192) IgG subclass 2 [Mass/volume] in Serum

856

2272

3.85

278.18

1.6

1.3

g/l

2.8

2.9

1.42

610

1586

(3024139) IgG subclass 3 [Mass/volume] in Serum

855

2272

3.84

277.39

1.6

1.3

g/l

0.4

0.00

609

1588

(3027135) IgG subclass 1 [Mass/volume] in Serum

855

2274

3.84

277.04

1.6

1.3

g/l

7.0

6.7

1.06

612

1585

(3013166) Neutrophils/100 leukocytes in Synovial fluid

388

508

7.72

276.97

1.8

1.2

46.4

58.1

5.84

346

418

(4062490)

854

2277

3.83

275.73

1.7

1.3

—

(3019150) Specific gravity of Urine by Refractometry

7540

50915

1.65

273.04

6.8

3.6

kg/l

1.0

1.60

957

7712

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1696

6814

2.58

270.94

2.8

2.6

—

(3032080) INR in Blood by Coagulation assay

11987

90447

1.55

269.78

8.6

8.1

inr

1.2

8.88

3921

26155

(3003458) Phosphate [Moles/volume] in Serum or Plasma

4867

29466

1.78

262.17

9.3

5.7

mmol/l

1.0

0.14

4634

27544

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

12194

92812

1.54

261.00

2.1

1.9

pmol/l

93.3

97.4

19.26

7315

47672

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1093

3593

3.12

254.22

1.7

1.4

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

3119

16577

1.99

251.91

2.4

2.3

au/ml

28.2

24.2

0.78

127

1036

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

504

955

5.35

250.33

1.1

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

654

1547

4.30

248.60

1.3

1.2

u/ml

15.1

7.7

0.80

104

(40768443) Skin Pathology biopsy report

2156

10012

2.24

248.49

1.3

1.2

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

336

425

7.98

246.99

1.5

1.2

41.3

38.6

0.47

248

262

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

668

1619

4.20

245.90

1.3

1.2

u/ml

82.6

65.5

0.62

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

2895

15123

2.01

245.22

1.3

au/ml

57.7

47.8

0.89

635

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

668

1624

4.18

244.89

1.3

1.2

u/ml

50.2

41.7

0.45

115

(3038026) Centromere Ab [Units/volume] in Serum

677

1664

4.14

244.57

1.3

1.2

u/ml

40.6

52.0

0.38

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1825

7958

2.38

243.63

2.1

2.0

ug/l

2.5

2.2

0.14

1634

7054

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

4052

23815

1.81

239.17

2.1

1.7

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

908

2774

3.34

238.29

1.9

1.5

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

646

1571

4.18

236.70

2.4

2.7

e6/l

628.8

723.7

1.87

298

580

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

683

1736

4.00

235.68

1.2

1.1

u/ml

82.7

49.9

1.05

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

4026

23714

1.81

235.63

2.0

1.7

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

3727

21485

1.84

233.97

3.1

2.3

g/l

0.2

9.04

3528

20041

(3052851) Hemolysis interference index of Serum or Plasma

1597

6699

2.46

232.07

3.2

3.1

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

405

673

6.09

231.25

1.9

1.7

u/ml

7599.8

42712.5

1.02

(3047189) Immunofixation for 24 hour Urine

434

771

5.70

231.20

2.8

1.5

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

10382

78250

1.50

221.84

3.4

mmol/l

2.3

2.4

25.34

9350

68554

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

1004

3413

3.01

220.00

1.3

—

(3025941) Bacteria identified in Stool by Culture

2650

14005

1.98

215.82

1.4

1.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

879

2800

3.20

215.29

1.7

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

835

2609

3.26

211.11

1.6

1.4

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1494

6351

2.42

210.44

1.8

1.7

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

535

1250

4.34

206.56

2.3

1.2

u/l

6.3

5.7

1.04

467

1051

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

749

2222

3.43

205.76

2.0

1.6

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

16541

137849

1.46

205.60

6.2

4.6

mmol/l

6.5

6.7

13.04

15723

128183

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1188

4583

2.66

205.13

1.5

1.6

—

(3020779) Urea [Moles/volume] in Serum or Plasma

3336

19380

1.81

202.16

12.1

7.4

mmol/l

9.3

9.2

0.62

3207

18530

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

8186

59858

1.51

196.84

3.6

2.8

ng/l

1293.2

1199.8

0.94

7137

50645

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1386

5869

2.43

196.68

1.5

1.3

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1073

4021

2.73

196.07

1.7

1.6

—

(3045414) Leukocytes [Presence] in Urine

2061

10293

2.08

195.72

2.0

1.8

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

751

2311

3.31

194.57

1.2

u/l

64.9

65.7

0.05

549

1513

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

896

3062

2.99

194.31

1.6

1.4

—

(3026250) Tacrolimus [Mass/volume] in Blood

454

986

4.66

192.21

39.5

35.4

ug/l

6.9

7.5

6.02

408

899

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

458

1005

4.61

191.45

1.1

miu/ml

1499.8

1522.9

0.15

458

1005

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

685

2017

3.45

190.33

2.0

1.7

—

(3017704) Immunofixation for Urine

441

956

4.67

187.13

2.7

1.3

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

9798

74916

1.46

185.92

3.3

2.5

u/l

58.2

57.9

0.14

9170

69074

(3045424) Erythrocytes [Presence] in Urine

1005

3750

2.74

185.08

1.6

1.5

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

5381

36428

1.58

181.42

3.7

2.8

e6/l

2.7

3.0

1.25

3192

19255

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

729

2304

3.22

180.73

2.1

1.6

—

(3016228) CD19 cells/100 cells in Blood

397

820

4.89

178.57

1.8

2.2

7.3

9.0

2.06

384

800

(3023103) Potassium [Moles/volume] in Serum or Plasma

26775

249750

1.82

177.43

21.7

14.6

mmol/l

3.9

4.0

35.49

26224

243062

(3019550) Sodium [Moles/volume] in Serum or Plasma

26713

249005

1.81

177.35

21.3

14.5

mmol/l

139.4

139.7

64.17

26214

242794

(44790049)

732

2355

3.16

176.13

2.1

1.5

—

(44790047)

732

2356

3.16

176.01

2.1

1.5

—

(44806118)

732

2356

3.16

176.01

2.1

1.5

—

(44790048)

732

2357

3.16

175.88

2.1

1.5

—

(3026008) Bacteria identified in Urine by Culture

9006

68411

1.46

174.00

3.4

2.9

—

(3033658) Prothrombin time (PT) actual/Normal

8116

60443

1.47

173.69

5.7

3.8

92.2

91.9

0.56

7923

58911

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

3069

18206

1.77

171.48

5.2

3.7

mmol/l

1.2

0.11

2842

15821

(3012095) Magnesium [Moles/volume] in Serum or Plasma

5428

37240

1.56

171.43

5.6

3.4

mmol/l

0.8

14.73

5112

34789

(21494814) CD8 cells/100 lymphocytes in Specimen

384

804

4.82

169.95

1.8

2.1

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

2856

16789

1.78

164.27

5.3

3.8

ng/l

84.9

88.7

1.10

2563

14573

(3006245) CD3-CD19+ cells/100 cells in Blood

396

885

4.52

161.80

3.1

2.1

9.2

11.6

2.71

362

834

(3042111) Morphology [Interpretation] in Bone marrow Narrative

873

3274

2.72

159.00

1.8

1.6

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1155

4953

2.39

158.85

1.6

1.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1066

4430

2.46

157.14

1.7

1.5

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1356

6353

2.19

151.05

9.2

3.7

mg/l

1.5

2.78

1273

5869

(40768441) Liver Pathology biopsy report

545

1607

3.44

151.03

1.5

1.4

—

(3013293) Extractable nuclear Ab [Presence] in Serum

212

281

7.59

149.75

1.7

1.5

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

7128

53000

1.45

149.42

2.2

1.7

mg/l

1.3

1.1

4.35

5598

40063

(42529582) MDA5 Ab [Presence] in Serum by Line blot

275

480

5.77

149.28

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

275

480

5.77

149.28

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

275

480

5.77

149.28

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

275

480

5.77

149.28

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

458

1221

3.79

147.64

2.5

2.8

42.5

38.5

2.23

151

413

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

308

605

5.13

146.90

2.2

3.6

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

960

3922

2.50

146.72

1.1

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

401

983

4.12

145.29

1.2

1.1

iu/ml

3.2

3.9

0.86

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

7494

56533

1.44

144.45

1.3

u/ml

1.2

1.7

4.18

1967

15392

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

373

871

4.32

144.12

2.8

2.1

27.9

29.2

0.88

352

834

(3007461) Platelets [#/volume] in Blood

28629

275568

2.57

141.65

41.6

18.2

e9/l

264.3

254.1

120.13

28425

268457

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

311

644

4.87

139.50

1.8

2.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

189

241

7.88

138.03

4.3

2.4

—

(3035941) MCH [Entitic mass]

28629

275781

2.54

137.54

41.2

18.1

30.7

30.2

307.65

28532

272112

(40768804) Tissue Pathology biopsy report

12031

98956

1.37

136.96

2.3

2.0

—

(3024731) MCV [Entitic volume]

28628

275806

2.53

136.80

41.3

18.1

92.6

90.6

307.65

28530

272124

(3026361) Erythrocytes [#/volume] in Blood

28629

275836

2.53

136.49

41.5

18.2

e12/l

4.4

4.5

307.65

28368

268000

(3010813) Leukocytes [#/volume] in Blood

28632

275890

2.53

136.26

41.5

18.2

e9/l

6.8

6.7

16.01

28376

268042

(40768797) Stomach Pathology biopsy report

4706

32782

1.52

134.76

1.3

1.2

—

(3000963) Hemoglobin [Mass/volume] in Blood

28629

275927

2.51

134.75

41.7

18.3

g/l

133.5

136.1

180.23

28533

272280

(3000060) B lymphocytes [#/volume] in Blood

310

660

4.73

134.51

3.0

2.1

e6/l

164.5

467.6

1.68

177

370

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

190

254

7.52

133.24

1.9

2.8

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

313

677

4.66

133.22

1.6

1.5

—

(40761511) CBC panel - Blood by Automated count

27165

257250

1.75

133.09

21.5

11.8

—

(3007916) DNA double strand Ab [Titer] in Serum

183

235

7.83

132.86

1.6

1.2

titre

124.8

192.9

0.27

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

451

1280

3.56

132.55

1.3

1.2

u/l

77.6

91.6

2.38

400

1110

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

442

1246

3.59

131.24

1.3

1.2

u/l

22.8

22.5

0.03

387

1058

(3018677) aPTT in Platelet poor plasma by Coagulation assay

4912

34753

1.50

129.98

3.2

2.1

29.7

0.06

4800

33698

(3044927) Protein electrophoresis panel - Urine

558

1834

3.08

129.37

1.3

1.2

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

547

1784

3.10

128.51

2.0

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

547

1784

3.10

128.51

2.0

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

547

1784

3.10

128.51

2.0

1.6

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

6418

47950

1.43

127.64

1.9

1.6

pmol/l

25179519.2

36257540.9

0.77

5584

39937

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

432

1224

3.57

127.30

3.5

2.3

u/ml

953.3

1096.0

0.53

421

1215

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1468

7561

1.99

126.56

2.8

2.3

ug/l

348.5

571.0

1.82

1335

7076

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

913

3909

2.38

125.73

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

456

1352

3.41

125.28

1.7

1.5

u/l

7.5

5.9

0.86

274

618

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

456

1370

3.36

122.68

2.3

1.4

u/ml

25.4

24.2

0.23

152

228

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

3425

22675

1.58

122.45

3.6

3.2

—

(3036670) Protein [Mass/volume] in Synovial fluid

268

550

4.91

121.53

1.4

1.2

g/l

39.9

0.00

160

280

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

3959

27197

1.53

119.64

4.0

2.7

umol/l

7.3

8.2

1.87

3444

23483

(21494434) Karyotype in Bone marrow

514

1697

3.06

118.24

1.2

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

210

355

5.95

117.91

6.6

5.7

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

26.73

116.84

7.4

3.3

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

16.49

115.61

5.3

2.5

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

515

1726

3.02

115.41

1.8

1.2

u/ml

—

30.2

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

15.76

115.30

5.5

2.5

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

2892

18680

1.61

114.28

3.1

2.5

ml/min/173m2

67.2

67.9

0.38

1173

7221

(3020876) Protein [Mass/time] in 24 hour Urine

513

1730

3.00

113.72

2.8

1.8

g/24h

0.8

1.2

0.49

109

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

255

532

4.82

113.43

1.3

1.2

—

(3037121) Protein [Mass/volume] in Urine

1453

7740

1.92

113.25

4.0

3.2

g/l

0.3

0.28

772

3397

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

472

1527

3.12

112.44

1.4

1.2

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

127

10.04

112.11

1.1

u/ml

31.1

40.1

0.36

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

127

10.04

112.11

1.1

u/ml

22.7

26.5

0.20

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

187

304

6.18

109.26

1.2

1.3

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

847

3731

2.31

109.17

1.3

1.2

u/ml

4.7

3.4

0.87

343

1257

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

10380

85639

1.33

107.21

4.0

3.3

ng/l

123.5

53.2

0.79

7008

54339

(40768446) Kidney Pathology biopsy report

334

894

3.77

107.11

2.0

1.7

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

3954

27736

1.49

107.02

8.8

7.1

mmol/l

104.4

0.43

3886

27147

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

629

2440

2.61

106.95

1.3

1.2

—

(3042631) Mycobacterium sp identified in Specimen

679

2735

2.52

106.78

2.8

2.6

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

126

138

9.16

104.01

4.2

2.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

354

1015

3.52

102.49

1.3

1.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

110

102

10.82

102.36

10.1

2.8

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

13174

112965

1.30

100.57

4.7

3.9

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

638

2567

2.52

100.56

2.1

33.1

32.5

2.62

629

2547

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

691

2904

2.41

99.11

1.7

1.4

—

(3005322) IgE [Units/volume] in Serum or Plasma

2484

16017

1.60

98.09

1.4

1.3

u/ml

392.3

223.8

3.02

2319

14825

(3024522) Salmonella sp identified in Specimen by Organism specific culture

689

2908

2.40

97.88

1.7

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

700

2979

2.38

97.62

1.7

1.4

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

142

196

7.27

96.87

1.5

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

447

1529

2.95

96.64

1.1

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

680

2884

2.39

95.56

1.7

1.4

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

800

3639

2.23

95.43

1.3

1.2

u/ml

4.0

3.8

0.14

371

1626

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

447

1540

2.93

95.40

1.1

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

130

165

7.91

95.37

4.4

4.2

mg/l

2.1

2.2

0.08

102

148

(3005988) Vibrio sp identified in Specimen by Organism specific culture

680

2887

2.39

95.33

1.7

1.4

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

347

1031

3.39

95.08

1.2

1.1

iu/ml

223.5

198.7

0.50

341

1023

(3025468) Yersinia sp identified in Specimen by Organism specific culture

678

2880

2.39

94.94

1.7

1.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

523

1965

2.69

94.80

1.1

—

(3028433) Virus identified in Specimen by Culture

277

709

3.93

94.70

1.2

—

(3002032) Base excess in Venous blood by calculation

3018

20514

1.52

94.15

7.1

4.0

mmol/l

1.8

1.9

0.22

2475

16830

(3012544) pH of Venous blood

3108

21282

1.51

93.61

7.1

4.0

7.4

0.03

112

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

5400

41045

1.39

92.78

2.8

3.0

mmol/l

2.5

2.4

2.40

4790

35858

(3021447) Carbon dioxide [Partial pressure] in Venous blood

3018

20582

1.52

92.60

7.2

3.9

kpa

5.8

1.85

2928

19998

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

491

1808

2.74

92.56

1.1

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

375

1193

3.17

91.95

1.5

1.2

titre

102.3

53.5

0.95

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

516

1957

2.67

91.81

1.2

1.1

mg/l

46.4

40.4

2.06

425

1656

(3006922) Hepatitis E virus Ab [Presence] in Serum

464

1677

2.79

90.65

1.1

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

380

1231

3.11

90.37

1.5

1.2

titre

351.8

544.1

0.53

(3003327) Ova and parasites identified in Stool by Light microscopy

1488

8608

1.77

88.49

1.7

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

497

1889

2.66

88.06

1.1

mg/l

241.0

260.7

1.48

426

1671

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

2226

14340

1.60

87.82

6.2

3.5

kpa

5.1

5.2

6.08

2088

13287

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1998

12543

1.64

87.64

1.8

1.6

—

(3000991) Gas panel - Venous blood

2801

19023

1.52

87.34

12.0

8.3

—

(21491868) Cryoglobulin [Mass/volume] in Serum

280

765

3.68

87.22

1.3

1.2

g/l

0.6

0.4

0.36

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

319

953

3.37

86.69

3.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

372

1220

3.07

86.64

1.8

1.4

—

(3009343) pH of Capillary blood

2198

14170

1.60

86.40

6.3

3.5

7.4

0.56

321

1775

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

627

2700

2.35

85.12

2.5

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

437

1590

2.77

84.32

1.8

1.5

—

(3042733) HLA Ab [Presence] in Serum

284

804

3.56

83.91

4.4

4.9

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

599

2552

2.37

83.32

1.3

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

173

338

5.14

83.17

1.7

1.3

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

2123

13695

1.59

83.11

6.3

3.5

mmol/l

1.6

1.7

0.88

1599

10093

(3013727) Leukocytes other/100 leukocytes in Blood

250

654

3.85

82.94

3.9

3.2

52.2

52.5

0.07

241

635

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

338

1076

3.17

82.83

2.2

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

336

1076

3.15

81.52

2.2

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

336

1076

3.15

81.52

2.2

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

336

1076

3.15

81.52

2.2

1.8

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1267

7203

1.79

79.82

4.8

2.6

g/l

3.5

3.6

0.23

1209

6858

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

103

123

8.40

79.49

4.4

1.5

—

(42529406) Shigella sp [Presence] in Stool by Culture

1244

7053

1.80

79.08

1.2

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

293

880

3.35

78.99

2.8

—

(4027681)

414

1517

2.75

78.83

1.3

1.2

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

3448

24867

1.44

78.82

8.4

7.4

kpa

5.0

5.1

6.18

3290

23784

(3014765) Yersinia sp identified in Stool by Organism specific culture

1240

7036

1.80

78.61

1.2

—

(3027801) Oxygen [Partial pressure] in Arterial blood

3445

24853

1.44

78.60

8.4

7.4

kpa

12.2

12.7

6.04

3291

23760

(3019060) Gas panel - Arterial blood

2147

14062

1.57

78.55

4.8

4.9

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1323

7692

1.75

77.13

4.4

2.3

93.6

92.2

1.45

1257

7142

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1227

6984

1.79

76.95

1.2

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

690

3235

2.16

76.31

1.1

g/l

1.5

2.00

644

2913

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

330

1088

3.06

76.21

1.8

1.5

—

(3023419) Bacteria identified in Sputum by Culture

591

2606

2.29

75.95

2.4

2.6

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

331

1099

3.03

75.51

1.8

1.5

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

3112

22189

1.45

75.41

2.8

2.5

u/l

40.3

45.6

0.43

2734

18975

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1753

11054

1.62

75.18

8.6

4.3

mmol/l

24.0

24.2

1.12

1603

9996

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1089

6032

1.84

74.71

1.9

1.3

mg/l

541.6

523.2

0.17

1050

5741

(3016502) Oxygen saturation in Arterial blood

3103

22185

1.45

74.02

8.8

7.8

95.6

95.8

1.31

2995

21359

(3024471) HLA-A [Type]

270

804

3.38

73.82

1.0

—

(3024932) HLA-DR beta [Type]

266

787

3.40

73.47

1.1

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

563

2473

2.30

73.01

1.1

au/ml

45.4

68.4

—

(3044640) Blood type and Crossmatch panel - Blood

8967

75311

1.27

72.94

3.1

2.3

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

7022

57184

1.30

72.82

3.0

2.3

—

(3003396) Base excess in Arterial blood by calculation

3411

24883

1.42

72.75

8.4

7.4

mmol/l

1.1

1.0

0.27

2702

19673

(4268621)

564

2509

2.27

70.99

2.4

2.3

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

326

1112

2.95

70.93

1.2

1.1

u/ml

29.6

10.3

0.77

113

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

159

333

4.79

70.55

1.2

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

147

288

5.12

70.51

2.2

2.0

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

2763

19523

1.46

69.92

9.0

7.1

mmol/l

1.3

0.74

2652

18844

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

273

847

3.24

69.89

2.4

2.0

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1493

9207

1.65

69.87

2.4

1.9

—

(3041672) Baker's yeast Ab [Presence] in Serum

107

8.43

69.72

1.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

270

834

3.26

69.63

2.4

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

270

834

3.26

69.63

2.4

2.0

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

972

5326

1.85

69.00

1.9

1.2

mmol/l

3.6

3.7

1.93

913

5008

(3048879) Bone marrow aspiration report

204

527

3.89

68.97

2.0

1.8

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

265

814

3.28

68.97

1.1

—

(3001729) Color of Synovial fluid

129

7.54

68.44

2.5

1.2

—

(3019225) pH of Specimen

3079

22317

1.42

67.75

6.2

4.0

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

137

263

5.23

67.26

10.8

8.8

umol/l

0.5

0.4

0.55

104

249

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

357

1317

2.73

67.16

1.2

1.1

u/l

1.1

0.28

172

590

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

610

2883

2.14

66.10

7.6

6.2

mg/l

11.5

11.4

0.29

569

2644

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

6085

49182

1.30

65.63

1.6

—

(3045142) Bone marrow Pathology biopsy report

525

2344

2.26

65.53

1.3

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

236

697

3.40

65.42

1.7

1.5

—

(3000093) Morphology [Interpretation] in Blood Narrative

479

2058

2.35

65.42

1.2

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

374

1434

2.63

65.21

1.2

1.1

ratio

1.1

0.14

150

497

(3044290) Cell count panel - Cerebral spinal fluid

912

4987

1.85

65.14

2.1

1.4

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

2504

17598

1.46

64.92

3.5

2.8

ng/l

176.8

178.4

0.07

2278

15967

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1195

7084

1.72

64.85

4.2

2.5

199.4

183.3

8.30

1136

6716

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1364

8394

1.65

64.27

2.0

1.8

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

505

2240

2.28

64.03

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

955

5334

1.82

63.69

2.1

1.4

e6/l

30.9

31.6

0.02

769

4103

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

955

5340

1.81

63.45

2.2

1.4

e6/l

1321.8

2683.3

0.69

804

4324

(3036489) Thrombin time

1451

9113

1.62

63.01

3.7

2.1

21.9

21.4

1.77

1282

7911

(3020961) Endomysium IgA Ab [Titer] in Serum

1845

12254

1.54

62.95

1.1

titre

157.6

201.2

0.30

323

(3006184) Hemoglobin [Mass/volume] in Capillary blood

911

5045

1.83

62.47

2.6

2.1

g/l

127.1

130.9

3.94

580

3713

(3024354) Oxygen [Partial pressure] in Venous blood

2404

16918

1.46

61.75

6.6

3.3

kpa

4.7

0.68

2318

16385

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1938

13097

1.51

60.92

1.6

1.5

—

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

85.25

60.89

1.2

1.3

mg/l

28.8

22.8

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1164

6970

1.70

60.83

5.1

3.2

u/ml

0.3

0.4

0.61

663

3966

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

853

4687

1.84

59.98

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

853

4688

1.84

59.94

1.4

1.3

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

178

466

3.84

59.13

1.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

246

794

3.11

59.03

1.1

—

(3022313) Gas panel - Capillary blood

1581

10303

1.56

58.64

7.0

3.7

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2074

14338

1.48

58.25

11.6

7.2

mmol/l

24.8

0.28

2059

14218

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

336

1294

2.61

58.12

1.2

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

312

1164

2.70

57.50

1.2

1.1

u/l

23.8

24.8

0.08

261

892

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

312

1164

2.70

57.50

1.2

1.1

u/l

77.8

86.7

0.97

271

922

(3002173) Hemoglobin [Mass/volume] in Arterial blood

2810

20615

1.40

57.11

9.4

8.2

g/l

118.6

122.0

15.16

2719

19876

(3035611) Eosinophils/100 leukocytes in Synovial fluid

108

7.52

57.05

2.8

1.3

0.4

0.8

0.76

(1616796) Gas panel - Central venous blood

886

5009

1.79

56.73

4.7

3.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

280

1005

2.80

55.59

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

280

1005

2.80

55.59

1.6

—

(4035726)

2794

20605

1.39

54.94

1.5

1.4

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

108

206

5.26

53.48

5.0

1.7

—

(40767503) Oxygen content in Capillary blood by calculation

836

4732

1.79

53.31

3.0

2.4

16.2

16.6

1.79

447

2418

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

275

1002

2.76

53.09

1.7

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

275

1002

2.76

53.09

1.7

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

334

1342

2.51

52.96

1.6

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

330

1321

2.51

52.74

1.6

1.4

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

430

1948

2.22

51.89

3.7

3.9

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

232

783

2.98

51.59

1.1

—

(3042951) Complement C1q Ab [Units/volume] in Serum

8.04

51.47

1.4

1.1

u/ml

25.7

16.8

0.60

(3027315) Oxygen [Partial pressure] in Blood

886

5166

1.74

50.97

5.0

3.8

kpa

8.7

0.42

873

5049

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

175

508

3.46

49.96

1.2

1.1

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

928

5527

1.70

49.42

4.8

2.9

mmol/l

24.3

24.7

2.01

825

4852

(3010421) pH of Blood

982

5939

1.68

49.37

4.9

3.8

7.4

3.28

860

5028

(3013290) Carbon dioxide [Partial pressure] in Blood

874

5138

1.72

48.82

5.0

3.8

kpa

4.9

5.0

4.10

861

5022

(3028626) Oxygen [Partial pressure] in Capillary blood

926

5531

1.70

48.79

7.9

3.4

kpa

8.7

8.5

1.44

873

5142

(3012501) Base excess in Blood by calculation

873

5137

1.72

48.60

5.0

3.8

mmol/l

2.3

2.5

0.98

628

3458

(3020891) Body temperature

1327

8669

1.56

48.54

5.1

5.0

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1386

9147

1.54

48.42

7.1

3.8

mmol/l

24.6

24.8

1.72

1310

8514

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

375

1653

2.28

48.36

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

373

1641

2.29

48.33

1.2

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

298

1192

2.51

47.75

1.6

1.5

umol/l

18.1

26.3

6.42

287

1135

(3022217) INR in Platelet poor plasma by Coagulation assay

3566

27862

1.32

47.63

21.8

22.2

inr

1.3

1.22

613

4009

(40758292) HTLV I+II Ab panel - Serum

136

349

3.91

46.57

1.6

1.3

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

173

5.33

46.33

1.0

1.1

u/ml

4.8

5.3

—

(3014051) Protein [Presence] in Urine by Test strip

871

5193

1.70

46.20

2.5

2.0

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

756

4333

1.76

46.20

4.2

3.1

—

(3014007) Fractional oxyhemoglobin in Arterial blood

1947

13880

1.43

46.17

10.6

9.3

93.8

94.0

0.91

1940

13828

(3026389) Candida sp identified in Specimen by Organism specific culture

651

3570

1.84

46.10

1.4

1.3

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

5293

43659

1.26

46.00

4.2

3.5

ng/l

385.4

488.2

0.80

3938

31968

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1904

13531

1.43

45.93

7.3

7.2

mmol/l

24.6

0.09

1775

12611

(3029075) Extractable nuclear Ab panel - Serum

205

699

2.95

44.83

1.1

—

(3051651) Icteric interference index of Serum or Plasma

322

1378

2.35

44.53

4.6

3.8

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1678

11727

1.46

44.23

3.5

2.6

e6/l

0.2

0.3

4.35

1640

11392

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

173

543

3.20

43.65

1.2

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

187

4.98

43.44

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

471

2381

1.99

42.67

4.3

3.3

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

139

386

3.61

42.52

3.1

2.5

mg/l

59.0

43.2

0.27

(36660697) Celiac disease serology panel - Serum

2680

20461

1.34

41.69

1.2

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1913

13842

1.41

41.59

10.6

9.2

1.3

1.4

1.91

1896

13752

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

586

3213

1.84

41.55

2.8

2.9

u/ml

166.5

575.7

0.69

576

3066

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

104

238

4.38

41.54

1.5

1.4

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

335

1503

2.24

41.49

1.2

1.1

—

(3028271) Lactate [Moles/volume] in Capillary blood

631

3543

1.80

41.38

2.1

1.8

mmol/l

1.7

0.70

615

3460

(3021901) Oxygen saturation in Capillary blood

685

3942

1.75

41.30

4.2

2.7

—

(3036603) Volume of Urine

338

1527

2.23

41.17

2.5

1.5

2027.4

1951.2

0.24

337

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

18055

168510

1.18

40.82

3.2

3.1

—

(3020393) Adenovirus Ag [Presence] in Stool

111

271

4.11

40.75

2.1

1.2

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1903

13810

1.40

40.65

10.8

9.3

0.7

2.27

1888

13728

(3044889) 12 lead EKG panel

17867

166688

1.18

40.28

3.9

3.5

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

115

292

3.95

40.03

1.9

1.6

—

(3016018) Differential panel - Cerebral spinal fluid

495

2615

1.91

39.44

2.0

1.4

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

654

3773

1.75

39.10

1.2

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

312

1394

2.25

39.07

1.5

1.4

u/l

13.7

12.3

1.75

300

1352

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

381

1844

2.08

38.96

1.1

mg/l

288.8

289.9

0.10

351

1653

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1812

24605

0.72

38.88

1.6

1.7

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1119

16550

0.66

38.55

1.4

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

20277

191621

1.19

37.85

4.1

pmol/l

14.9

14.7

28.05

18749

175483

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

205

775

2.66

37.00

1.3

1.2

—

(3018405) Lactate [Moles/volume] in Arterial blood

1128

7547

1.51

36.89

3.9

4.3

mmol/l

1.3

1.4

0.54

1106

7418

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

23610

226417

1.22

36.76

4.8

mu/l

1.8

2.1

8.17

22014

209185

(3013005) Retinol [Moles/volume] in Serum or Plasma

255

1073

2.39

36.73

2.4

1.9

umol/l

2.0

1.9

0.98

244

1003

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

2387

18265

1.33

36.34

2.3

ug/l

8.9

7.1

1.51

2080

15982

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

290

1296

2.25

36.33

1.1

—

(3022621) pH of Urine by Test strip

2031

15210

1.36

35.66

3.9

2.7

—

(3023410) Appearance of Cerebral spinal fluid

465

2489

1.88

35.63

3.0

1.5

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

196

4.45

35.50

1.1

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1406

9906

1.44

35.37

4.7

3.0

0.7

3.05

1348

9500

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1457

10345

1.43

35.14

1.1

u/ml

11.0

8.8

0.10

140

(3022806) Fractional oxyhemoglobin in Capillary blood

517

2876

1.81

35.03

1.9

1.8

90.1

89.9

0.34

505

2831

(3008536) Aspergillus sp Ab [Presence] in Serum

138

433

3.20

34.95

2.3

2.2

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

112

309

3.63

34.69

1.2

1.4

nmol/l

8.0

272164.4

2.09

255

(1761868) Lipid panel - Serum or Plasma

8118

91429

0.84

34.46

2.6

2.7

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

972

6395

1.54

34.38

1.2

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1770

13067

1.38

33.97

1.4

—

(3012565) Volume of 24 hour Urine

262

1155

2.28

33.95

3.0

2.1

2030.3

1988.8

0.26

240

1030

(3013247) Albumin in CSF/Albumin in Serum or Plasma

157

542

2.91

33.72

1.1

mg/g

7.1

6.7

0.25

147

511

(3004119) Hemoglobin [Mass/volume] in Venous blood

1772

13102

1.37

33.68

5.3

3.4

g/l

125.3

129.9

14.95

1724

12804

(3009542) Hematocrit [Volume Fraction] of Blood

23835

229249

1.21

33.54

28.5

13.3

39.5

40.0

17.96

17146

172018

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1585

11541

1.39

33.06

11.5

9.5

mmol/l

24.4

24.3

0.29

1465

10821

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

114

329

3.47

33.01

6.3

5.0

ug/min

38.8

44.2

0.48

250

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1419

10140

1.42

33.00

4.6

3.0

1.2

1.3

1.60

1410

10085

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

443

2403

1.86

32.60

1.1

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

309

1483

2.09

32.40

3.7

2.1

100.5

96.7

1.06

297

1374

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

6.51

32.24

1.0

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

222

932

2.39

32.22

4.2

3.8

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

342

1712

2.01

31.99

1.4

umol/l

12.7

11.8

1.57

334

1626

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

619

3722

1.68

31.88

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

362

1851

1.97

31.87

1.3

1.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

383

2004

1.92

31.52

3.1

2.8

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

601

3597

1.68

31.51

1.1

121.8

118.2

1.73

560

3243

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

186

728

2.56

31.39

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

417

2250

1.87

31.23

1.4

1.6

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

133

439

3.04

30.97

1.4

1.2

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

158

575

2.76

30.81

1.1

—

(3012516) Albumin [Mass/volume] in Urine

7536

66594

1.18

30.20

4.0

3.2

mg/l

1031.5

366.8

13.35

5157

41464

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1013

6911

1.48

30.13

1.5

1.4

ug/g

281.1

276.8

0.27

590

3969

(4306422)

613

3732

1.66

30.12

1.2

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

271

1273

2.14

30.10

1.1

—

(21494755) Public health laboratory ask at order entry panel

2142

27342

0.77

29.61

1.3

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1002

6853

1.48

29.43

1.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1176

8293

1.44

29.42

1.3

miu/ml

217.7

225.0

0.26

435

3905

(3013512) EKG study

7417

65579

1.17

29.35

3.8

3.7

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

609

3749

1.64

28.67

1.1

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

1402

10242

1.39

28.63

4.7

3.4

mmol/l

25.2

25.3

0.11

1359

9930

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

312

1583

1.98

28.16

1.1

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

461

2657

1.75

27.79

1.1

96.1

95.5

0.16

434

2496

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

175

706

2.49

27.78

1.1

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

153

579

2.65

27.71

1.7

2.0

u/l

22.5

40.4

1.79

130

527

(3009508) Creatinine [Moles/volume] in Urine

8184

73195

1.16

27.63

3.8

3.2

mmol/l

7.4

7.7

4.49

7112

61865

(3011325) HIV 1+2 Ab [Presence] in Serum

101

5.35

27.47

1.0

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

211

932

2.27

27.33

1.2

—

(3043409) Potassium [Moles/volume] in Arterial blood

950

6542

1.47

26.96

4.1

4.6

mmol/l

3.9

0.00

906

6150

(3005011) Chlamydia sp Ab [Titer] in Serum

103

319

3.24

26.77

1.4

1.6

—

(3034426) Prothrombin time (PT)

194

837

2.33

26.57

1.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

154

605

2.55

25.89

1.1

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

148

574

2.59

25.55

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

458

2707

1.70

25.26

1.1

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

17728

167859

1.14

25.25

4.0

3.0

u/l

51.8

45.8

12.29

16765

157579

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

151

599

2.53

24.90

1.1

—

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

10.01

24.68

1.1

1.0

iu/ml

37.7

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

339

1851

1.84

24.57

1.2

1.3

mmol/l

2.2

2.1

0.49

317

1722

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

122

439

2.79

24.42

1.3

1.2

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1573

12007

1.33

24.13

12.4

9.7

—

(3003181) Sodium [Moles/volume] in Urine

578

3684

1.58

23.64

1.6

1.4

mmol/l

65.3

64.0

0.31

459

2917

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

379

2175

1.75

23.28

1.7

1.3

—

(3009015) Lactate [Moles/volume] in Synovial fluid

213

3.57

23.14

1.5

1.2

mmol/l

5.6

5.8

0.15

103

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

209

986

2.13

23.09

1.1

1.2

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

206

973

2.12

22.70

4.1

5.1

mg/l

1521.5

2376.5

0.31

169

700

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

259

1337

1.94

22.36

1.3

u/l

19.7

13.3

1.44

241

1237

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

147

607

2.43

22.31

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1023

7419

1.39

21.84

1.3

1.4

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

187

864

2.17

21.82

1.2

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

228

3.38

21.59

1.1

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1258

9448

1.35

21.55

5.0

3.9

49.6

48.9

0.45

1237

9355

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

253

3.25

21.54

2.7

1.2

u/ml

61.6

87.6

—

(3020682) Albumin/Creatinine [Ratio] in Urine

7731

69918

1.14

21.05

4.6

4.0

mg/mmol

12.8

8.8

1.12

5220

43682

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

144

608

2.37

20.84

1.1

—

(3000330) Specific gravity of Urine by Test strip

1441

11099

1.31

20.72

3.9

3.3

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

255

1365

1.88

19.79

1.2

1.1

nmol/l

10.3

4.1

1.36

254

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

321

2.87

19.60

1.7

1.6

—

(3036048) Francisella tularensis Ab [Titer] in Serum

128

528

2.43

19.54

1.2

1.1

titre

704.0

597.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

134

567

2.37

19.34

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

102

4.51

19.30

1.4

1.3

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

248

1328

1.87

19.25

1.1

1.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

196

972

2.02

19.06

1.1

1.2

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

124

4.12

19.03

3.4

4.9

—

(3017569) Oxygen content in Arterial blood

186

910

2.05

18.78

2.2

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

539

3574

1.52

18.56

1.9

2.1

titre

7.8

7.5

0.01

(3023183) Ammonium ion [Moles/volume] in Plasma

689

4807

1.44

18.37

2.9

2.8

umol/l

32.3

34.5

2.10

606

4079

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

188

932

2.02

18.32

1.1

1.2

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

124

4.04

18.18

1.1

1.0

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

244

3.08

18.11

1.1

—

(3012441) Differential panel - Pleural fluid

331

1966

1.69

18.09

1.5

—

(3032057) Clostridioides difficile [Presence] in Stool

110

439

2.51

18.06

2.0

1.7

—

(3022229) Phosphate [Moles/volume] in Urine

157

3.63

17.90

1.8

2.7

mmol/l

19.5

19.9

0.04

135

(4034850)

1022

7654

1.35

17.87

12.5

8.8

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1165

8908

1.32

17.67

5.7

5.0

1.6

1.7

1.66

1095

8338

(3003434) Protein [Mass/volume] in Pleural fluid

404

2540

1.60

17.65

1.5

1.4

g/l

34.4

33.7

0.47

375

2301

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

223

1189

1.88

17.59

1.3

59.6

64.0

0.26

133

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

232

1258

1.85

17.37

1.6

—

(3000492) Spirometry study

2861

24322

1.19

16.97

1.7

1.4

—

(3035933) Granulocytes/100 leukocytes in Blood

153

725

2.12

16.87

1.6

1.7

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

22782

221161

1.13

16.83

5.6

5.4

mmol/mol

38.5

39.4

38.10

21506

205656

(3047007) Chlamydophila sp Ab [Presence] in Serum

554

3775

1.48

16.75

1.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1505

11991

1.27

16.65

2.4

—

(3023199) Leukocytes [#/volume] in Pleural fluid

368

2303

1.61

16.43

1.5

e6/l

3108.8

3054.1

0.03

258

1667

(3047181) Lactate [Moles/volume] in Blood

937

7023

1.34

16.33

6.5

5.8

mmol/l

1.3

0.30

823

6204

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

224

3.04

16.12

1.2

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

368

2.56

16.12

2.1

1.2

ng/l

910.5

111.9

0.47

236

(3007930) Methemoglobin/Hemoglobin.total in Blood

1134

8751

1.31

16.11

5.9

5.1

0.9

0.63

1065

8198

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

291

1725

1.69

16.09

1.4

1.3

u/l

546.7

471.3

0.56

280

1642

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

4.74

16.06

1.3

1.1

—

(3018133) Calcium [Moles/volume] in Urine

105

435

2.42

15.98

1.8

2.2

mmol/l

2.3

2.7

1.29

386

(3046861) Legionella sp Ag [Presence] in Urine

4.23

15.90

1.0

1.1

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

4.47

15.82

1.4

1.3

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

202

3.12

15.65

1.6

mg/l

3.7

4.3

0.23

134

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

202

3.12

15.65

1.6

mg/l

0.8

2.4

3.13

154

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

202

3.12

15.65

1.6

mg/l

1.8

1.2

0.31

130

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

202

3.12

15.65

1.6

mg/l

1.7

2.4

0.38

140

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

202

3.12

15.65

1.6

mg/l

2.0

2.8

0.62

148

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

202

3.12

15.65

1.6

mg/l

1.3

1.9

0.68

133

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

202

3.12

15.65

1.6

mg/l

0.5

1.1

1.74

140

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

202

3.12

15.65

1.6

mg/l

1.4

1.7

0.33

147

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

202

3.12

15.65

1.6

mg/l

2.5

3.0

0.26

142

(40757373) Influenza virus identified in Isolate

101

416

2.43

15.58

2.0

1.6

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

127

578

2.20

15.55

1.2

1.1

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

208

3.08

15.54

1.6

mg/l

1.1

2.0

0.93

140

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

202

1088

1.86

15.51

4.7

2.0

ug/l

57.0

190.6

1.02

194

1034

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

286

1710

1.68

15.34

1.4

1.2

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

123

556

2.22

15.32

1.7

1.5

ug/l

0.3

0.4

4.94

372

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

205

3.08

15.27

1.2

1.1

—

(3036782) Glucose [Moles/volume] in Pleural fluid

298

1803

1.66

15.27

1.4

1.3

mmol/l

5.9

6.3

1.83

272

1667

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

186

3.18

15.09

1.2

—

(40765096) Chromosome analysis panel by Banding

131

612

2.14

15.05

1.2

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

183

966

1.90

14.97

1.1

—

(3016244) Insulin [Units/volume] in Serum or Plasma

282

1696

1.67

14.81

3.1

3.3

mu/l

23.4

27.7

1.08

271

1591

(40761539) Cells [Type] in Urine sediment by Light microscopy

123

566

2.18

14.69

1.2

—

(3049717) Cytology report of Urine Cyto stain

1000

7696

1.31

14.53

2.4

2.6

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

443

2979

1.49

14.38

1.5

1.8

titre

14580.0

2941.6

—

135

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

3289

28691

1.16

14.19

8.2

6.4

—

(40768806) Pleura Pathology biopsy report

316

1978

1.60

14.17

1.6

1.5

—

(3004451) EKG impression Narrative

182

978

1.87

14.13

1.4

1.3

—

(3024928) Oxygen saturation in Venous blood

649

4700

1.39

14.12

5.9

3.6

—

(3045788) Cell count panel - Pleural fluid

289

1774

1.63

14.04

1.5

—

(3016038) Potassium [Moles/volume] in Urine

242

1418

1.71

14.04

1.4

1.3

mmol/l

32.1

34.9

1.17

204

1228

(4010399)

2083

17497

1.20

14.02

1.5

1.4

—

(3010937) Rubella virus Ab [Presence] in Serum

136

3.46

13.80

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

2447

28524

0.84

13.75

1.7

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

176

946

1.87

13.67

1.2

1.1

ng/l

342.9

669.0

0.67

216

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

733

9745

0.75

13.45

3.5

1.6

mg/l

6.8

3.3

4.54

579

6790

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

219

1267

1.73

13.33

1.9

1.7

u/field

1.6

2.6

2.36

149

911

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

110

505

2.18

13.26

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

116

3.62

13.23

3.2

3.4

—

(44806071)

311

2.51

12.97

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

306

2.52

12.90

1.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

618

4511

1.38

12.86

3.2

3.4

u/ml

284.1

931.4

2.50

558

4114

(3052592) Norovirus Ag [Presence] in Stool

418

2.28

12.72

1.6

1.3

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

324

2104

1.55

12.47

1.5

e6/l

51475.8

50848.6

0.01

181

1249

(3050129) First trimester maternal screen panel - Serum or Plasma

602

8137

0.73

12.38

1.5

1.4

—

(3010838) Calcium [Moles/time] in 24 hour Urine

202

1169

1.73

12.32

1.5

1.6

mmol/24h

5.5

5.6

—

104

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

6.00

12.10

5.0

3.3

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

143

749

1.91

12.09

1.2

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

926

7237

1.29

12.04

1.1

u/ml

5.1

5.9

0.15

986

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

271

4209

0.64

11.94

2.6

3.6

u/ml

22.9

39.2

5.40

258

4058

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

3236

28545

1.15

11.90

1.9

2.0

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

486

3457

1.41

11.82

1.2

1.3

u/l

45.7

32.7

1.91

439

3005

(3001186) Copper [Moles/volume] in Serum or Plasma

123

617

2.00

11.80

1.2

1.3

umol/l

16.7

17.0

0.15

111

548

(3000012) Reticulocyte production index

199

1166

1.71

11.64

1.5

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

561

4101

1.37

11.61

1.1

au/ml

14.6

11.8

0.34

250

(3039000) Anion gap in Blood

657

4929

1.34

11.51

7.7

6.8

mmol/l

11.2

0.06

597

4435

(3023383) Lactate [Moles/volume] in Pleural fluid

113

555

2.04

11.51

1.3

mmol/l

3.7

3.4

0.41

103

515

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

443

2.17

11.50

1.3

1.4

32.4

22.0

2.26

382

(3018572) Chloride [Moles/volume] in Blood

657

4930

1.34

11.49

7.7

6.8

mmol/l

105.1

105.2

0.07

597

4436

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

3543

31552

1.14

11.30

2.0

2.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

240

3773

0.63

11.20

4.6

5.3

umol/l

351.0

372.4

1.56

201

3299

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

100

474

2.11

11.20

1.3

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

100

475

2.11

11.14

1.3

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

100

475

2.11

11.14

1.3

1.1

—

(3035880) pH of Pleural fluid

177

1019

1.74

11.06

1.3

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1003

8005

1.26

11.03

3.4

3.5

u/ml

414.1

2310.9

1.52

858

6837

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

252

2.54

11.00

1.1

—

(3016750) Collection duration of Urine

209

1268

1.65

10.77

2.7

2.2

min

506.5

498.2

0.56

166

962

(3040151) Glucose [Moles/volume] in Capillary blood

367

2526

1.46

10.73

4.3

9.0

mmol/l

7.3

7.4

0.11

308

2066

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

471

6460

0.72

10.70

1.4

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

304

2.37

10.67

1.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

471

6455

0.73

10.65

1.4

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

458

3290

1.40

10.58

3.1

2.1

umol/l

10.1

7.1

1.75

347

2405

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

471

6444

0.73

10.54

1.4

—

(4015189)

110

554

1.99

10.49

1.8

2.3

—

(3045716) Anion gap in Serum or Plasma

164

939

1.75

10.47

2.9

2.5

mmol/l

8.7

9.3

1.33

128

677

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

469

6413

0.73

10.46

1.4

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

147

3.00

10.32

1.2

1.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

107

537

2.00

10.32

1.8

1.2

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

280

2.40

10.18

1.2

1.1

—

(3015183) Erythrocyte sedimentation rate

210

1295

1.63

10.18

1.3

1.2

—

(3002619) Bacteria identified in Specimen by Culture

467

2.06

10.09

1.5

1.2

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

129

3.10

9.97

1.1

—

(3007919) Fasciola sp Ab [Titer] in Serum

5.43

9.90

1.2

1.0

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

201

2.64

9.86

1.4

1.3

ml/s/173m2

1.4

1.6

0.27

140

(3035637) Corticotropin [Mass/volume] in Plasma

438

3163

1.39

9.85

1.7

1.5

—

(3044009) aPTT.lupus sensitive (LA screen)

219

2.56

9.80

1.3

1.2

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

374

2.17

9.76

1.2

1.1

pmol/l

3.9

3.5

0.11

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

274

2.37

9.71

1.2

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

158

2.85

9.69

1.2

1.0

—

(3002256) Pathology report gross observation

3501

31457

1.13

9.63

1.3

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

997

12228

0.81

9.62

1.5

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

3.48

9.58

2.3

1.3

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

210

2.57

9.57

1.1

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

199

2.62

9.52

1.2

1.1

u/l

19.5

21.8

0.43

134

(3035320) C reactive protein [Mass/volume] in Body fluid

269

1786

1.51

9.48

2.9

2.3

—

(3019174) dRVVT (LA screen)

218

2.53

9.38

1.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

2999

26733

1.14

9.36

1.5

1.4

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

5.14

9.34

1.0

1.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

274

2.34

9.25

1.3

mmol/l

0.8

1.4

0.61

179

(3001019) Free T4 and TSH panel - Serum or Plasma

1193

14284

0.83

9.05

1.7

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

116

3.11

9.02

8.1

10.6

e6/l

407.2

149.8

0.53

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

103

537

1.92

8.97

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

262

1754

1.50

8.91

1.8

1.7

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

128

2.97

8.84

1.0

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

345

2.15

8.75

1.1

—

(3006969) Lambda light chains [Mass/volume] in Urine

4.75

8.57

1.1

1.0

g/l

0.2

0.0

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

6819

63754

1.09

8.54

1.7

mmol/l

1.4

0.03

5878

53842

(3024316) Viscosity of Plasma

100

3.20

8.45

1.2

1.6

mpas

1.6

1.5

0.20

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

200

2.50

8.41

1.2

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

3.46

8.34

1.3

1.1

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

130

747

1.74

8.31

1.3

1.2

27.2

19.8

0.50

118

(3005033) Fetal Nuchal fold Thickness US

383

5205

0.73

8.31

1.4

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

3.51

8.21

1.0

1.1

u/field

1.2

1.3

0.14

(3002523) Influenza virus A Ag [Presence] in Specimen

546

4197

1.31

8.20

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

546

4199

1.31

8.18

1.1

—

(3041184) Isoniazid [Presence] in Urine

6.09

8.17

2.6

2.9

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

385

5208

0.74

8.11

1.4

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

147

882

1.67

8.04

2.7

2.3

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

129

748

1.73

8.01

1.2

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

398

5339

0.74

7.94

1.4

1.5

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

203

1321

1.54

7.94

1.5

1.2

u/l

232.8

331.9

1.42

189

1226

(3026470) Cobalt [Mass/volume] in Blood

194

1250

1.56

7.93

2.0

ug/l

3.6

3.7

0.03

170

1101

(3027456) Digoxin [Moles/volume] in Serum or Plasma

470

3558

1.33

7.90

3.1

nmol/l

0.8

0.07

353

2740

(3019420) Tryptase [Mass/volume] in Serum or Plasma

206

1350

1.53

7.81

1.5

ug/l

8.3

8.2

0.02

185

1226

(3025577) Chromium [Mass/volume] in Blood

189

1216

1.56

7.79

2.1

ug/l

2.2

2.4

0.48

158

1010

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

533

6844

0.77

7.73

1.4

1.5

—

(3020618) Glucose [Moles/volume] in Synovial fluid

3.64

7.71

1.1

mmol/l

5.0

5.1

0.06

(40768793) Breast Pathology biopsy report

443

5816

0.76

7.62

1.3

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

241

2.28

7.62

1.2

1.3

u/l

635.1

224.3

0.29

177

(3020650) Glucose [Presence] in Urine

111

626

1.78

7.61

1.7

1.4

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

151

2.65

7.60

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

255

2.24

7.52

1.1

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

355

2.03

7.43

1.3

1.2

mmol/l

1.9

1.8

0.37

217

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

136

2.72

7.40

1.3

1.1

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

3.73

7.33

7.1

8.2

—

(3028707) Methadone [Presence] in Urine by Screen method

365

4890

0.74

7.26

2.3

2.9

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1193

10125

1.19

7.26

2.1

2.3

u/l

7397.0

5434.8

0.80

367

3968

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

195

2907

0.67

7.26

1.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

490

3779

1.30

7.25

1.1

u/ml

3.5

3.0

0.20

165

1874

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

132

2.73

7.24

1.3

1.7

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

3.48

7.24

3.6

3.4

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

459

5951

0.77

7.21

1.5

—

(40757494) Bilirubin.total [Moles/volume] in Blood

186

1215

1.53

7.20

2.6

2.2

umol/l

29.0

31.8

0.07

116

(4212803)

179

2.46

7.20

1.0

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

105

2.95

7.20

1.1

1.2

—

(4198724)

1345

0.52

7.15

2.3

2.4

—

(3017400) Magnesium [Moles/volume] in Urine

3.92

7.14

1.2

1.1

mmol/l

3.1

3.4

0.13

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

377

2818

1.34

6.97

2.4

2.0

mg/l

26.6

25.2

0.19

111

748

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

114

667

1.71

6.92

1.4

1.7

iu/ml

—

381.5

—

(3019832) Treponema pallidum Ab [Presence] in Serum

2798

25290

1.12

6.90

1.6

1.7

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

136

2.65

6.86

1.0

1.2

u/field

1.2

1.1

0.08

(40768800) Prostate Pathology biopsy report

273

3785

0.72

6.81

1.2

—

(3004775) Volume in Urine collected for unspecified duration

247

1731

1.43

6.76

2.5

2.3

785.2

667.1

3.19

181

1205

(3044416) Complement C4 [Mass/volume] in Pleural fluid

3.07

6.71

1.1

1.2

g/l

0.1

0.06

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

3.88

6.69

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

602

4820

1.25

6.62

1.3

1.4

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

259

1842

1.41

6.55

1.3

u/ml

0.7

1.1

0.41

108

822

(3039443) Prostate specific Ag panel - Serum or Plasma

300

4060

0.74

6.45

1.6

—

(3003129) Base excess in Capillary blood by calculation

558

1.74

6.30

1.9

1.7

mmol/l

0.5

0.8

0.28

521

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

3.57

6.29

5.1

5.3

mg/l

9.2

5.1

0.52

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3.16

6.27

1.0

—

(43055187) t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

+∞

6.25

4.0

0.0

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

252

1803

1.40

6.18

2.1

2.0

u/field

2.1

2.2

0.12

121

802

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

242

2.11

5.91

4.2

2.8

mg/l

1.9

1.2

0.58

167

(3000764) Benzodiazepines [Presence] in Urine

958

11239

0.85

5.88

1.7

2.1

—

(3028300) Cannabinoids [Presence] in Urine

967

11335

0.85

5.87

1.7

2.1

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

181

1231

1.47

5.87

1.6

2.0

174.6

137.4

5.99

169

1157

(3027008) Opiates [Presence] in Urine

965

11309

0.85

5.85

1.7

2.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

167

1120

1.49

5.81

1.1

94.3

98.1

0.97

136

883

(3046914) Granular casts [#/area] in Urine by Computer assisted method

4.17

5.81

1.3

1.5

u/field

0.7

0.6

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

1607

0.61

5.75

11.2

12.0

mmol/l

0.6

0.22

1481

(3044242) Glucose [Moles/volume] in Arterial blood

148

971

1.53

5.72

2.1

—

(3027944) Amphetamines [Presence] in Urine

949

11115

0.85

5.72

1.7

2.0

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

3.46

5.71

1.0

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

126

1944

0.65

5.66

1.0

—

(3016879) Cocaine [Presence] in Urine

891

10475

0.85

5.62

1.7

2.2

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

101

609

1.66

5.58

1.3

nmol/l

122.4

127.5

0.12

441

(3011288) Drugs identified in Urine by Screen method

625

7578

0.82

5.55

2.2

3.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

217

1544

1.41

5.55

1.2

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

521

1.71

5.49

1.3

ug/l

372.6

290.4

0.10

283

(46236302) HLA-C [Type] by High resolution typing

2.84

5.49

1.0

—

(4281824)

198

2781

0.71

5.45

1.1

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

3.46

5.44

1.2

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

732

8725

0.83

5.43

1.8

2.2

—

(3025315) Body weight

199

2.16

5.34

5.2

4.2

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

213

2.11

5.29

1.4

58.7

72.9

1.85

185

(3014271) Vancomycin [Susceptibility]

146

973

1.50

5.28

2.8

2.9

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

130

845

1.54

5.28

1.1

95.0

91.3

0.47

382

(3006270) Folate [Moles/volume] in Blood

252

1855

1.36

5.28

1.2

1.1

nmol/l

349.3

371.6

1.00

222

1590

(3003338) MCHC [Mass/volume]

21752

213834

1.07

5.23

35.6

15.7

g/l

331.2

332.7

120.01

21666

212302

(3050794) Legionella sp Ab [Presence] in Serum

188

2.18

5.22

1.1

1.2

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

138

2.39

5.19

1.1

u/l

1.9

3.3

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

3.13

5.17

1.1

—

(3015350) Toxocara sp Ab [Presence] in Serum

4.44

5.03

1.0

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

261

0.23

5.02

7.3

7.5

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

1329

0.60

5.01

1.3

1.4

nmol/l

31.2

30.6

0.07

1210

(3021691) Plasmodium malariae Ab [Titer] in Serum

4.78

5.00

1.9

2.7

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1016

8796

1.16

4.96

1.5

—

(3019977) pH of Arterial blood

170

1184

1.44

4.95

2.8

2.5

7.4

0.42

390

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

131

867

1.51

4.93

1.1

94.3

90.7

0.61

385

(40763590) HLA-DQ beta [Type]

2.73

4.92

1.0

—

(40760410) HLA-B [Type] by High resolution

2.73

4.92

1.0

—

(40760409) HLA-A [Type] by High resolution

2.73

4.92

1.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

240

2.00

4.90

1.1

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

132

882

1.50

4.76

1.1

1.2

110.6

108.8

0.20

122

793

(3025130) Human papilloma virus identified in Specimen

453

3661

1.24

4.73

2.0

1.7

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

3.94

4.70

1.0

1.1

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

4.40

4.55

1.6

1.4

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

353

4443

0.79

4.54

1.4

1.5

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

2.80

4.53

1.0

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

497

1.65

4.52

1.9

2.7

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

10.00

4.51

1.0

1.1

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

10.00

4.51

1.0

1.1

—

(3030313) Adrenal Ab [Titer] in Serum

242

1.94

4.46

1.1

—

(3018291) Platelet Ab [Presence] in Serum

4.00

4.43

1.0

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

24520

242320

1.07

4.41

4.4

4.3

mmol/l

4.6

4.7

42.28

23068

226258

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

563

1.60

4.39

1.1

1.2

83.3

88.6

0.44

156

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

2522

23241

1.09

4.27

3.3

4.1

ug/l

20.0

24.8

0.37

1963

18555

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

444

5411

0.82

4.26

1.9

1.8

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

403

1.69

4.12

2.7

2.4

—

(3013862) HLA-DP [Type]

2.53

4.11

1.0

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

280

2180

1.29

4.07

2.3

nmol/l

21.5

19.2

2.26

266

2067

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

169

2.07

3.99

1.2

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1232

13791

0.89

3.99

2.4

3.4

u/ml

46.5

52.5

0.42

1176

13333

(40768795) Lymph node Pathology biopsy report

302

2386

1.27

3.92

1.2

—

(3000034) Microalbumin [Mass/volume] in Urine

269

2097

1.28

3.89

3.1

3.0

mg/l

51.2

49.0

0.06

216

1469

(43055442) Apixaban [Mass/volume] in Serum or Plasma

263

1.83

3.83

1.3

1.5

ug/l

138.9

105.5

1.14

219

(3008295) Osmolality of Serum or Plasma

289

2279

1.27

3.82

1.4

1.5

mosm/kgh2o

278.4

280.3

0.69

227

1774

(3006462) Nitrate [Presence] in Urine

158

1144

1.38

3.80

5.5

2.8

—

(4211845)

170

1248

1.36

3.76

5.2

2.7

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

132

929

1.42

3.74

1.7

2.0

200.6

159.3

3.17

125

879

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

324

1.73

3.73

1.3

1.4

54.4

54.5

0.00

165

(3033942) Copper [Moles/time] in 24 hour Urine

102

2.35

3.72

1.1

umol/24h

0.4

0.6

0.49

(3006442) Creatine [Moles/volume] in Serum or Plasma

220

1682

1.31

3.71

1.6

1.5

umol/l

63.8

70.1

1.80

130

(3028468) Fragments [Presence] in Blood by Light microscopy

6.67

3.67

1.0

2.3

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

148

2.10

3.66

1.1

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

162

2.04

3.63

1.1

1.2

26.5

21.2

0.26

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

136

2.13

3.59

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

143

2.10

3.57

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

3425

36394

0.93

3.56

2.7

2.9

ug/l

0.7

2.26

2263

23095

(40758047) Lysozyme [Mass/volume] in Pleural fluid

178

1.97

3.51

1.1

mg/l

10.3

10.1

0.04

162

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

122

1712

0.71

3.51

1.5

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

131

933

1.41

3.50

1.2

g/l

0.3

1.85

109

747

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

6.15

3.49

1.0

1.2

—

(3012898) Urea [Moles/volume] in Urine

235

1.83

3.49

1.2

1.5

mmol/l

189.8

170.3

0.40

213

(3011985) Renin [Units/volume] in Plasma

408

3385

1.21

3.42

1.6

1.5

mu/l

68.5

65.5

0.12

359

3018

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

227

1764

1.29

3.42

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

689

5978

1.16

3.40

1.2

1.3

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

147

2.04

3.34

1.1

1.6

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

3.44

3.32

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

3.44

3.32

2.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

3.44

3.32

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

3.44

3.32

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

3.44

3.32

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

3.44

3.32

2.0

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

142

2.04

3.24

1.3

1.5

umol/24h

329.0

320.1

0.08

142

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

246

1946

1.27

3.24

1.8

1.5

g/l

0.9

1.0

1.74

246

1938

(3003694) ABO and Rh group [Type] in Blood

7236

69710

1.05

3.21

1.5

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

367

0.41

3.21

1.2

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

264

1.74

3.21

2.7

2.6

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

1247

0.68

3.17

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

909

0.63

3.17

2.5

3.0

umol/l

27.3

28.5

0.54

689

(3017937) Magnesium [Moles/time] in 24 hour Urine

2.62

3.12

1.4

1.3

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

179

1.90

3.12

1.1

iu/ml

49.8

10.1

1.31

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

678

1.45

3.12

1.4

49.5

63.8

2.88

569

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

566

1.49

3.06

1.2

67.4

75.1

0.90

151

(3000919) Neutrophils/100 leukocytes in Pleural fluid

512

1.50

3.00

1.5

1.3

34.0

20.5

3.04

473

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

4.09

2.87

1.2

1.4

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

4.09

2.87

1.2

1.4

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

867

7737

1.12

2.86

1.5

1.4

u/l

10.8

10.2

0.64

717

6295

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

258

2089

1.24

2.83

1.3

nmol/l

1.6

1.4

1.70

234

1880

(3001893) Eosinophils/100 leukocytes in Pleural fluid

569

1.46

2.81

1.5

1.4

3.4

2.8

0.20

492

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

137

1025

1.34

2.79

1.9

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

451

1.51

2.72

1.4

1.6

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

3.75

2.66

1.0

1.1

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

446

1.50

2.64

2.6

5.1

u/l

37.1

58.0

1.19

177

(3027874) Urate [Moles/volume] in Urine

2.39

2.62

1.0

1.1

mmol/l

1.7

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

24812

246033

1.05

2.62

4.7

mmol/l

2.7

2.8

81.44

23216

228444

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

328

1.59

2.60

1.2

1.3

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

24282

240658

1.05

2.60

4.3

4.2

mmol/l

1.5

24.19

22737

223771

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

216

1734

1.25

2.59

1.1

iu/ml

9.9

8.0

0.30

440

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

4.00

2.56

9.1

2.3

—

(3024869) Neuronal Ab [Presence] in Serum

401

1.52

2.56

1.0

1.1

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

156

1.86

2.55

1.0

1.1

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

116

1.98

2.44

1.1

1.3

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

23467

232474

1.05

2.44

4.0

3.8

mmol/l

1.3

0.18

21923

214926

(3051387) C reactive protein [Mass/volume] in Capillary blood

443

5109

0.86

2.41

4.2

3.2

mg/l

27.7

26.3

0.36

267

3203

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

335

1.55

2.41

1.1

u/ml

0.0

0.3

1.43

210

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

710

6336

1.12

2.40

2.2

1.8

iu/l

4.5

11.5

1.12

249

2386

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

110

2.00

2.39

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

367

3130

1.17

2.38

1.4

pmol/l

335.0

307.9

0.61

292

2426

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

2.21

2.36

1.0

1.1

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1747

16285

1.08

2.35

3.0

3.4

pmol/l

4.4

4.5

1.86

1561

14549

(44813793)

235

1927

1.22

2.35

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

299

3547

0.84

2.34

1.4

1.3

mmol/l

7.2

0.10

216

2597

(3014133) Dog dander IgE Ab [Units/volume] in Serum

335

3932

0.85

2.31

1.1

u/ml

5.4

4.7

0.20

130

1595

(40760512) CD34 cells/100 cells in Bone marrow

4.61

2.27

1.5

1.7

—

(44806420)

584

0.62

2.26

2.2

2.3

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

127

1.89

2.25

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1038

9489

1.10

2.24

1.6

1.7

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

115

871

1.32

2.23

1.5

1.4

pmol/l

15.1

14.9

0.16

101

729

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

114

864

1.32

2.21

1.2

113.3

111.4

0.30

777

(3027540) Rickettsia typhi Ab [Titer] in Serum

2.78

2.19

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

313

3675

0.85

2.19

1.0

1.1

u/ml

3.7

5.0

0.95

127

1569

(3020356) Listeria sp identified in Specimen by Organism specific culture

143

1.82

2.17

1.1

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

108

1.94

2.14

1.2

1.6

u/l

0.2

0.0

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

144

1.81

2.13

1.1

1.5

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

375

3238

1.16

2.13

1.3

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

851

9348

0.91

2.10

1.7

1.9

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

471

0.59

2.07

1.4

1.2

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

5.00

2.07

1.2

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

5.00

2.07

1.2

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

3.50

2.05

1.0

1.1

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

3.08

2.01

1.0

1.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

751

6804

1.11

1.99

1.8

1.7

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

161

1990

0.81

1.99

1.2

1.3

pmol/l

74.6

127.5

0.60

614

(3027231) Wheat IgE Ab [Units/volume] in Serum

561

1.37

1.96

1.0

1.1

u/ml

2.7

2.4

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

995

9146

1.09

1.95

1.5

1.4

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

439

4973

0.88

1.92

1.1

u/ml

5.0

5.5

0.29

228

2635

(3006576) Bicarbonate [Moles/volume] in Blood

104

797

1.31

1.91

5.2

6.7

mmol/l

24.2

25.1

1.96

732

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

117

911

1.29

1.91

2.4

2.3

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

2.24

1.90

1.1

1.2

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

172

0.41

1.89

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

293

3405

0.86

1.86

1.4

ug/l

3.0

3.9

1.51

265

2987

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

407

1.43

1.85

5.0

1.9

mmol/l

1.2

0.09

395

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

491

1.39

1.85

1.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1594

16965

0.94

1.85

1.2

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

159

1.70

1.84

1.4

pmol/l

18.2

17.5

0.08

132

(40761995) Spermatozoa Progressive [#/volume] in Semen

683

0.69

1.83

3.4

3.2

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

682

0.69

1.81

6.7

6.4

—

(4146454)

205

2445

0.84

1.79

2.6

2.8

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

137

1098

1.25

1.78

1.5

2.1

umol/l

114.7

133.5

0.26

550

(3012494) Peanut IgE Ab [Units/volume] in Serum

102

789

1.29

1.77

1.1

u/ml

2.3

7.4

0.59

461

(40765089) Chromosome analysis panel - Blood by G-banded

806

0.72

1.76

1.0

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

4857

50165

0.96

1.76

3.8

4.1

21.6

21.8

0.48

2255

22982

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

1.89

1.74

1.2

1.3

u/field

1.2

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

111

1405

0.79

1.74

1.6

2.0

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

547

6071

0.90

1.72

1.4

pmol/l

134.4

135.7

0.02

529

5931

(3008401) Mugwort IgE Ab [Units/volume] in Serum

422

4748

0.89

1.69

1.1

u/ml

2.2

1.1

0.95

181

2097

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

601

5440

1.11

1.68

2.8

2.4

ug/min

83.9

110.7

1.42

343

3262

(43055514) Macroprolactin [Presence] in Serum or Plasma

705

0.71

1.67

1.6

1.4

—

(44786800) Granulocytes/100 leukocytes in Body fluid

235

1.53

1.66

1.3

35.8

22.6

1.27

179

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

104

1.83

1.66

1.1

1.0

u/ml

0.0

0.1

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

2.80

1.64

1.1

1.3

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

413

4637

0.89

1.62

1.1

u/ml

2.4

0.00

102

1188

(3014891) Appearance of Pleural fluid

229

1.53

1.61

1.4

1.6

—

(3032641) Amino acids panel - Urine

2.50

1.59

1.4

1.3

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

2.69

1.58

1.0

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

191

1609

1.19

1.56

1.0

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

160

1.63

1.55

1.0

1.1

u/l

14.6

8.3

0.27

160

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1896

18007

1.06

1.53

1.2

iu/ml

111.3

147.0

4.27

680

6803

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

159

0.44

1.53

1.0

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

276

3154

0.87

1.46

1.0

1.1

u/ml

1.2

0.4

0.63

728

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

163

1.60

1.45

5.7

4.7

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.97

1.43

1.0

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

221

1.49

1.40

1.2

1.0

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

205

1.51

1.39

1.1

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

2.41

1.39

1.1

1.0

—

(3007733) Chloride [Moles/volume] in Urine

2.00

1.37

1.5

1.6

mmol/l

109.1

80.7

0.95

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

119

1.68

1.37

1.1

1.0

u/ml

0.0

0.1

—

(4024509)

248

2161

1.15

1.37

1.6

1.5

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

2.61

1.36

1.0

1.1

—

(3004982) Buprenorphine [Mass/volume] in Serum or Plasma

0.00

1.34

0.0

2.8

—

2.4

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

183

1.53

1.33

1.4

1.5

35.4

34.1

0.05

122

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

619

1.28

1.32

2.3

2.8

ng/l

103.5

117.0

0.46

327

(3021387) Prolactin [Units/volume] in Serum or Plasma

889

9521

0.93

1.32

1.6

mu/l

285.9

313.9

1.90

793

8619

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

394

3543

1.11

1.32

1.3

nmol/l

0.6

1.4

1.04

378

3407

(40762814) Titanium [Mass/volume] in Blood

367

1.36

1.31

2.3

ug/l

3.9

0.03

125

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

152

1.58

1.31

1.0

u/ml

13.9

18.2

0.31

126

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

2.09

1.30

1.1

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

276

1.41

1.27

1.5

1.4

12.4

13.1

0.06

143

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.94

1.27

1.0

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

112

920

1.22

1.26

2.2

2.7

ug/l

1.4

1.2

0.45

106

867

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

101

1235

0.82

1.25

1.1

1.3

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

392

3538

1.11

1.25

1.2

1.3

nmol/l

0.3

0.2

0.14

220

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

504

5502

0.91

1.23

1.1

u/ml

1.7

1.6

0.04

212

2299

(3022689) Creatine [Moles/volume] in Urine

698

1.25

1.22

1.6

1.5

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

540

1.28

1.19

1.5

1.4

g/l

11.5

13.5

0.93

412

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

310

2775

1.12

1.17

1.2

1.3

nmol/l

18.9

32.2

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

2.05

1.15

1.0

1.1

—

(3013336) Amino acids [Identifier] in Serum or Plasma

1.72

1.14

1.5

3.1

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

143

1.54

1.10

2.3

6.2

19.8

3.33

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

127

1498

0.85

1.10

1.0

ng/l

337.6

334.8

0.03

1063

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

3300

32010

1.03

1.08

1.6

1.8

1.5

1.4

6.95

2880

28384

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

153

1.50

1.05

1.0

1.2

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

186

1.45

1.05

2.4

2.2

55.3

58.2

0.13

109

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

590

1.24

1.01

7.6

8.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

396

4317

0.92

0.99

1.2

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

475

1.26

0.99

1.3

1.4

g/l

22.6

29.2

1.10

367

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

317

1.32

0.98

1.0

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

187

2121

0.88

0.98

1.3

1.5

promille

1.2

1.4

1.04

144

1591

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

318

0.69

0.95

2.2

3.6

umol/l

39.9

40.7

0.06

279

(3027923) C peptide [Moles/volume] in Serum or Plasma

150

1303

1.15

0.95

1.4

1.6

nmol/l

1.3

1.2

0.57

116

1023

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

387

0.72

0.94

1.0

1.2

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

166

1886

0.88

0.92

1.6

mmol/l

7.8

7.7

0.05

105

1152

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

167

1.44

0.91

1.3

1.2

ug/l

90.9

114.6

0.49

106

(3036312) Salmon IgE Ab [Units/volume] in Serum

151

1.46

0.90

1.1

u/ml

1.3

1.5

0.07

114

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

103

0.49

0.89

1.2

—

(3006567) Chloride [Moles/time] in 24 hour Urine

1.86

0.87

1.3

1.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

131

1505

0.87

0.86

1.0

ng/l

40.9

42.4

0.15

1048

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

131

1503

0.87

0.85

1.0

ng/l

782.2

740.3

0.49

1028

(3008116) Ketones [Moles/volume] in Urine by Test strip

504

1.23

0.85

1.3

1.4

—

(3001218) Citrate [Mass/time] in 24 hour Urine

1.94

0.84

1.8

1.4

—

(3019298) Eosinophils/100 leukocytes in Peritoneal fluid

1.78

0.84

1.3

1.4

0.4

0.3

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.59

0.84

1.1

1.2

nmol/l

254.6

272.9

0.24

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

108

1253

0.86

0.83

1.1

u/ml

11.7

9.0

0.15

227

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

136

1190

1.14

0.81

3.0

2.2

u/l

203.4

202.4

0.06

136

1181

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

444

1.24

0.81

2.2

2.3

mmol/l

8.2

7.4

0.34

252

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.57

0.81

1.1

1.3

nmol/l

501.6

515.1

0.05

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

126

1441

0.87

0.80

1.4

mmol/l

5.5

5.7

1.29

117

1358

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

482

1.22

0.79

1.2

1.9

ug/l

2.8

0.00

288

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

145

1640

0.88

0.78

1.1

1.3

g/l

1.5

—

102

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

535

5019

1.07

0.78

1.9

pmol/l

197.2

196.4

0.07

508

4770

(3028717) Thiamine [Mass/volume] in Blood

269

1.30

0.77

1.1

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

347

3207

1.08

0.77

1.2

1.3

—

(3042517) Benzodiazepines panel - Urine

360

0.75

0.76

2.1

2.8

—

(3008037) Lactate [Moles/volume] in Venous blood

487

4560

1.07

0.76

3.7

3.1

mmol/l

1.5

1.6

2.69

469

4468

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

382

0.76

0.75

1.0

ug/l

83.0

79.7

0.21

313

(3012989) Citrate [Moles/time] in 24 hour Urine

1.84

0.73

2.0

1.4

mmol/24h

2.2

2.0

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

124

1407

0.88

0.72

1.3

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

176

1.36

0.72

4.5

3.4

23.3

9.8

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

281

1.28

0.72

1.0

u/ml

0.3

0.1

0.58

175

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

598

1.19

0.71

1.2

pmol/l

451.7

305.5

0.68

436

(3023511) Choriogonadotropin [Units/volume] in Urine

544

5128

1.06

0.71

1.4

1.3

—

(3041354) Potassium [Moles/volume] in Venous blood

275

2533

1.09

0.68

2.9

2.3

mmol/l

4.1

4.0

0.22

270

2514

(4094501)

618

6517

0.95

0.68

1.1

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.53

0.68

1.0

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

293

1.26

0.67

2.9

2.4

u/field

0.8

0.6

0.46

293

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

102

1.47

0.67

5.9

10.0

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

223

1.30

0.66

2.2

2.1

—

(3007463) Buprenorphine [Presence] in Urine

129

0.62

0.63

1.5

8.0

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

303

0.76

0.63

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

288

2672

1.08

0.62

1.0

1.1

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

1.63

0.62

1.4

2.3

mu/l

2.0

3.0

—

(3035285) Chloride [Moles/volume] in Venous blood

273

2532

1.08

0.60

2.9

2.3

mmol/l

105.5

105.6

0.11

268

2513

(3044590) Delta aminolevulinate [Moles/volume] in Urine

0.00

0.60

0.0

1.1

—

15.5

—

(3012138) Guinea pig epithelium IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.0

—

2.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

528

1.17

0.58

7.7

8.0

—

(3051101) Glucose [Moles/volume] in Cord blood

365

0.79

0.57

3.9

5.8

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1.67

0.56

1.0

1.1

—

(3018001) Oat IgE Ab [Units/volume] in Serum

176

1.31

0.56

1.0

u/ml

0.4

0.2

—

(3036180) Methadone [Presence] in Urine

1.45

0.56

1.1

2.9

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

1.48

0.53

1.2

1.4

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

6382

63025

1.02

0.53

4.1

4.7

ug/l

2.3

2.9

2.72

5733

56971

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

1109

0.89

0.52

2.0

2.1

ug/min

53.5

116.6

0.94

237

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.62

0.52

1.0

—

(3022475) Manganese [Moles/volume] in Blood

168

0.71

0.50

1.5

1.2

—

(3044007) Cell count panel - Peritoneal fluid

633

1.14

0.48

2.3

1.9

—

(3029396) Erythrocyte agglutination [Presence] in Blood

699

0.87

0.47

2.8

—

(3017509) Phencyclidine [Presence] in Urine

322

0.81

0.47

2.0

1.8

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

138

1507

0.92

0.47

1.1

1.0

u/ml

0.2

0.9

1.16

216

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.41

0.43

1.1

1.0

—

(4038314)

196

0.76

0.42

1.2

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

371

0.84

0.42

1.1

1.2

—

(3011897) Casein IgE Ab [Units/volume] in Serum

471

1.15

0.42

1.3

u/ml

31.6

5.9

0.38

112

(3013762) Body weight Measured

0.63

0.42

1.0

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

264

2491

1.06

0.41

3.0

2.3

—

(3003577) Lead [Moles/volume] in Blood

206

0.78

0.41

1.8

1.4

umol/l

0.2

—

(3042628) Porphyrins [Moles/volume] in Urine

0.00

0.41

0.0

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

256

2415

1.06

0.40

4.3

4.8

u/ml

105.6

114.7

0.09

748

(1002224) Polysomnography panel

1061

10900

0.97

0.40

1.1

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

174

1621

1.07

0.40

2.3

3.4

nmol/l

155.5

130.1

0.26

164

1603

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

1.47

0.40

1.0

g/l

176.0

163.4

—

(3038515) Glucose [Moles/volume] in Venous blood

447

4282

1.04

0.40

3.9

3.1

mmol/l

7.2

7.5

1.95

433

4205

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

101

0.69

0.39

1.0

1.1

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

475

1.14

0.38

2.1

1.5

nmol/l

0.2

0.32

340

(36303858) Crystals [Presence] in Urine

1.39

0.38

1.2

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

107

981

1.09

0.37

1.0

1.1

—

(3014339) Estrone (E1) [Moles/volume] in Serum or Plasma

1.30

0.37

1.0

1.2

pmol/l

278.2

413.8

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

23570

235062

1.01

0.36

4.3

4.4

mmol/l

5.8

5.9

21.56

21846

216445

(3001556) Androgen free Index in Serum or Plasma

277

0.83

0.35

1.2

1.3

—

(3041806) Other cells [#/volume] in Blood by Manual count

973

0.91

0.35

1.8

1.4

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

199

1.21

0.34

1.1

1.0

—

(3029612) Listeria sp Ab [Titer] in Serum

1.36

0.34

1.0

1.3

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

4382

43336

1.01

0.33

1.5

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.30

0.33

1.0

1.3

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

263

0.84

0.32

1.0

1.1

umol/24h

1.7

0.01

263

(4133840)

712

1.10

0.32

1.2

—

(3009677) Dengue virus Ab [Presence] in Serum

101

1.29

0.31

1.1

1.2

—

(3043410) Blood group antigens tested for on Red Blood Cells

617

1.10

0.31

1.8

1.7

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

484

1.12

0.31

1.3

1.2

mg/l

145.5

34.5

0.49

352

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

334

3475

0.96

0.30

1.5

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

217

2280

0.95

0.30

1.3

mmol/l

12.1

11.8

0.14

545

(3032868) Hemoglobin electrophoresis panel in Blood

228

0.83

0.29

1.5

1.6

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

130

1.23

0.28

1.1

1.0

—

(3051593) INR in Capillary blood by Coagulation assay

100

930

1.08

0.28

7.1

9.7

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

536

1.10

0.28

1.1

umol/24h

0.6

0.8

0.73

266

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

327

1.13

0.27

2.3

2.5

mmol/l

1.2

1.3

0.08

228

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

261

1.15

0.27

2.0

—

(1761482) Bacteria [#/volume] in Urine by Culture

565

5492

1.03

0.27

4.7

4.0

—

(40758358) Immune stain study

117

0.77

0.27

1.0

—

(46235168) Fasting glucose [Moles/volume] in Blood

289

0.86

0.26

1.2

2.0

mmol/l

5.6

7.5

—

(3049242) von Willebrand panel - Platelet poor plasma

1.30

0.26

1.5

1.6

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

819

1.07

0.25

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.22

0.25

1.0

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

131

1237

1.06

0.25

3.0

6.2

u/ml

5162.3

3199.0

—

260

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

387

1.11

0.25

6.6

7.5

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

326

3148

1.04

0.24

1.4

1.7

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

198

1.16

0.24

1.5

1.8

umol/l

40.7

47.8

0.69

198

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

274

2640

1.04

0.24

1.7

2.0

ug/l

24.5

24.2

0.03

264

2588

(3034092) Cytoplasmic Ig cells/100 cells in Blood

328

0.88

0.23

16.4

8.0

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

153

1455

1.05

0.23

1.3

umol/l

3.6

4.9

4.91

134

1338

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

199

1.16

0.23

1.0

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

494

0.91

0.22

1.5

1.9

—

(3013931) Oligosaccharides [Presence] in Urine

0.00

0.21

0.0

1.1

—

(40761895) Polymorphonuclear cells/100 leukocytes in Peritoneal dialysis fluid

0.00

0.21

0.0

2.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1439

14187

1.01

0.21

1.8

1.9

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

430

1.09

0.21

7.6

5.8

67.8

69.2

0.15

340

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

413

4238

0.97

0.20

1.3

u/l

27.4

27.9

0.11

343

3461

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

117

1.20

0.20

10.2

10.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

503

4913

1.02

0.20

1.6

1.7

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

271

0.89

0.20

1.0

1.3

mmol/l

—

1.8

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.18

0.19

1.0

1.1

2.3

2.6

—

(3016031) Almond IgE Ab [Units/volume] in Serum

184

1.14

0.19

1.0

1.1

u/ml

0.3

1.0

—

108

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

156

1624

0.96

0.18

2.0

1.8

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

805

1.06

0.17

2.4

2.0

e6/l

369.8

2699.6

1.34

550

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

351

0.91

0.17

1.2

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

320

1.09

0.17

1.1

1.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

402

4107

0.98

0.16

1.5

1.4

nmol/l

0.3

0.4

0.50

299

3170

(3020491) Glucose [Moles/volume] in Blood

187

1809

1.03

0.16

1.9

1.8

mmol/l

6.8

6.7

0.12

144

1309

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

273

1.10

0.16

1.1

1.0

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

2875

28954

0.99

0.16

4.0

4.4

33.5

32.1

8.62

2191

20010

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.77

0.15

1.2

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

477

1.07

0.15

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

369

0.92

0.15

1.2

1.1

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.80

0.14

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

160

1.12

0.14

1.2

1.3

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

391

3985

0.98

0.13

1.1

iu/ml

49.3

3131.1

0.67

899

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1775

17895

0.99

0.13

1.9

2.0

—

(37021550) Renin [Units/volume] in Plasma --upright

529

1.06

0.13

1.2

1.3

mu/l

218.4

78.0

0.43

394

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

676

1.05

0.13

3.2

2.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

676

1.05

0.13

3.2

2.5

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

114

1.14

0.11

2.2

3.2

—

0.0

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

135

1390

0.97

0.11

1.4

1.9

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

192

1.09

0.10

1.0

u/ml

0.1

1.7

1.86

134

(3020874) Milk IgE Ab [Units/volume] in Serum

175

1709

1.02

0.10

1.1

u/ml

10.6

2.2

0.57

526

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

228

0.92

0.10

1.3

1.2

mg/l

45.9

46.5

—

(3012403) Metanephrines [Moles/time] in 24 hour Urine

1.11

0.09

1.0

1.1

—

30.3

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

166

0.90

0.09

1.0

—

(3049233) Organic acids panel - Urine

1.04

0.09

1.2

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

123

1198

1.03

0.09

1.6

1.8

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

1.05

0.08

1.0

1.6

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

719

7254

0.99

0.08

1.7

nmol/l

41.6

40.8

0.32

703

7064

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

115

1179

0.97

0.08

1.6

nmol/l

3.1

10.1

0.83

987

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

706

1.03

0.08

2.5

1.8

e6/l

5440.9

10927.2

0.69

381

(3034614) HLA Ag [Interpretation]

1.08

0.08

1.1

1.2

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

1.04

0.07

1.0

1.1

mmol/l

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

488

4830

1.01

0.07

2.6

2.1

nmol/l

1.0

0.8

4.48

423

4043

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

265

1.06

0.06

1.2

1.1

u/ml

0.1

0.9

1.44

150

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

267

2704

0.99

0.06

2.4

3.3

nmol/l

6.6

8.1

0.23

254

2620

(3014599) Egg white IgE Ab [Units/volume] in Serum

170

1671

1.02

0.06

1.1

u/ml

4.7

4.9

0.02

447

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

161

1583

1.02

0.06

6.0

6.6

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

1332

13253

1.00

0.06

1.5

1.4

iu/l

27.8

28.2

0.13

1144

11391

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

168

1.07

0.05

1.1

u/ml

6.1

7.6

0.14

122

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1378

13836

1.00

0.05

1.1

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

495

1.03

0.05

1.2

1.1

u/ml

2.1

6.4

1.26

361

(3033799) Differential panel - Peritoneal fluid

694

1.02

0.04

2.3

1.9

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

328

1.04

0.04

1.0

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

160

1.06

0.04

2.4

2.3

—

(3037556) Urate [Mass/volume] in Serum or Plasma

654

0.98

0.04

1.7

1.3

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

171

1.05

0.03

1.0

u/ml

1.4

1.3

0.05

133

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

271

1.03

0.02

1.2

1.0

u/ml

0.1

2.1

0.85

149

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

163

1616

1.01

0.02

1.3

1.5

—

(3006598) pH of Arterial cord blood

124

1.05

0.00

1.1

1.0

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1750

17502

1.00

0.00

2.2

nmol/l

12.9

12.5

1.54

1561

15627

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

110

1095

1.00

0.00

2.1

2.5

umol/l

53.7

54.2

0.05

933

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

185

0.97

0.00

1.0

1.1

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

246

1.02

0.00

1.1

u/ml

0.2

0.4

0.66

143

(3000285) Sodium [Moles/volume] in Blood

276

1.01

0.00

1.1

—

(3005117) Influenza virus A Ab [Titer] in Serum

0.00

0.0

1.0

—

(3022670) pH of Venous cord blood

0.98

0.00

1.2

1.0

—

(3020399) Glucose [Mass/volume] in Urine

0.00

0.0

1.7

—

(3006392) Corynebacterium diphtheriae [Presence] in Specimen by Organism specific culture

0.00

0.0

1.0

—

(40771459) Voltage-gated potassium channel Ab [Moles/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3027114) Cholesterol [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(1175312) AMPAR1 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.0

1.0

—

(3003195) risperiDONE [Mass/volume] in Serum or Plasma

0.00

0.0

1.4

—

(3016072) Theophylline [Mass/volume] in Serum or Plasma

0.00

0.0

1.1

—

(1176058) AMPAR2 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.0

1.0

—

(3025311) HLA-B [Type]

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint RX_CROHN_2NDLINE and mortality.

Females

Parameter	HR [95% CI]	p-value
RX_CROHN_2NDLINE	1.489 [1.37, 1.62]	< 0.001
Birth year	0.997 [0.99, 1.0]	0.426

During the follow-up period (1.1.1998 — 31.12.2019), 9945 out of 74466 females with RX_CROHN_2NDLINE died.

Males

Parameter	HR [95% CI]	p-value
RX_CROHN_2NDLINE	1.482 [1.35, 1.63]	< 0.001
Birth year	0.988 [0.98, 1.0]	0.01

During the follow-up period (1.1.1998 — 31.12.2019), 7804 out of 50876 males with RX_CROHN_2NDLINE died.

Mortality risk

Mortality risk for people of age

years, who have RX_CROHN_2NDLINE.

N-year risk	Females	Males
1	0.109%	0.213%
5	0.853%	1.45%
10	2.094%	3.974%
15	4.265%	7.84%
20	7.491%	13.469%

Relationships between endpoints

↥

Index endpoint: RX_CROHN_2NDLINE – Second line medication for Crohn's disease

GWS hits: 41

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Second line medication for Crohn's disease

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints